Subject index to volume 108

SUBJECT INDEX TO VOLUME 108 Abcesses Crohn's disease and, 108:1396 crypt, NO in primate colitis and (rhesus macaque), 108:705 A b d o m i n a l i r r a d i a t i o n , radiation-induced microvascular dysfunction and (rat), 108:1761 A b d o m i n a l pain basic and clinical aspects of, 108:947-br colonic sarcoidosis and, 108:1556-cr intestinal permeability and, 108:1576-srr multiple focal nodular hyperplasia of liver and, 108:1256-cr sphincter of Oddi dysfunction and, 108:242-cr Aberrant crypt foci, in colorectal carcinogenesis, 108:434, 108:600-e, 108:1609-e Absorptive c e l l s , genetic hemochromatosis and, 108:2-tmig, 108:208 Absorptive hyperemia, lymphatic system and, 108:1599-ss Abstinence, chronic alcohol abuse and, 108:776 ACE inhibition, colon cancer and, 108:1322-ss Acetaldehyde, alcoholic, anti-hydroxyethyl free radical-modified albumin and, 108:l-tmig, 108:201

4-Acetamido4'-isothiocyanatostilbene-2-2'disulfonic acid gastric mucosal pHi regulation and (Nectutus, 108:999 hepatic glucuronidation and (rat), 108:183 Acetate, gastric ethanol metabolism and (rat), 108:737 [*3]Acetate breath test, for gastric emptying, 108:957-tmig, 108:1048 Acetazolamide, duodenal HCO3 secretion and, 108:102 A c e t i c acid, colitis induced by, dexamethasone-fl-D-glucuronide and (rat), 108:1688 A c e t y l m e s a l a m i n e , intestinal delivery of, 108:1427 Achalasia, DNA ploidy and dysplasia in, 108:545-cr

Achlorhydria, epidermal growth factor stability in gastric juice and, 108:92

Acid

Ad2/CFTR2, CF-IBE ceils and, 108: 584-rc

Adenine nucleotide, fructose-l,6-bi-

esophageal mucosal injury and, 108:1897srr secondary biliary cirrhosis and (rat), 108:1183 Acid-loading, pancreatic H+/HCO3 - secretion and (pig), 108:850 Acid perfusion, esophageal sensitization in noncardiac pain and, 108:311

Acid suppressants epidermal growth factor stability in gastric juice and, 108:92 Helicobacter felis and, 108:1386

Acidity beverage, heartburn and, 108:2-tmig, 108:125 epidermal growth factor stability in gastric juice and, 108:92 human spasmolytic polypeptide and, 108:108 A c i n a r c e l l s , pancreatitis and (rat), 108:1863 Acinar necrosis, IL-10 in pancreatitis and, 108:1917-rc

Acquired immunodeficiency syndrome (AIDS) cryptosporidiosis with, 108:624-tmig, 108:627, 108:957-tmig, 108:1075 intestinal permeability and, 108:1575-srr octreotide and, 108:1753, 108:1939-e Actin bile canalicular contraction and, 108:841 dietary ammonium-induced hypergastrihernia and (rat), 108:320 pancreatitis and (rat), 108:1863 Actinomycin D, interleukin lfl and (rat), 108:1720 A c t l v i n A, liver regeneration and (rat), 108:1136 Activin-follistatin system, in hepatoma ceils, 108:834

Acute lymphoblastic leukemia (ALL), intestinal permeability and, 108:1576-srr

phosphate and (rat), 108:1785

Adenocarcinoma colon, cell surface antigen in (nude mice), 108:172 esophageal, 108:310-tmig, 108:337

Adenoma ampullary, 108:242-cr colorectal c-yes tyrosine kinase activity in, 108:117, 108:291-e incidence and recurrence, 108:309tmig, 108:402 K-ras-2 mutations in, 108:1040 NSAIDs and, 108:1310-e

Adenosine triphosphate (ATP) chronic alcohol abuse and, 108:776 enteric inhibitory neurons and, 108:554srr liver cell necrosis and, 108:258-srr 2',5'-Adenylate synthetase, interferon c~ and (rat), 108:1192

Adenylyl cyclase activating peptide, pituitary, enteric inhibitory neurons and, 108:554-srr

Adhesion molecules, polymorphonuclear leukocyte margination and (rat), 108:393

Adolescents Crohn's disease in, 108:957-tmig rumination syndrome in, 108:1024 Adrenalectomy, pancreastatin and (rat), 108:1445 Adrenaline, ileal crypts and (mouse), 108:1345

Adrenocorticotropic hormone (ACTH), dexamethasone-fl-D-glucuronide and (rat), 108:1688

Afferent neutrons, rectoanal inhibitory reflex and, 108:1700 A f r i c a , hepatitis E virus infection and, 108:l-tmig A G M - 1 4 7 0 , angiogenesis in pancreatic cancer and (Syrian hamster), 108:1526 A l a n ~ e , refrigerated donor livers and, 108:1510

Alanine aminotransferase (ALT) KEY TO ABBREVIATIONS aga--American Gastroenterological Association br--Book Reviews cr--Case Reports c--Correspondence e--Editorials

rc--Rapid Communications ss--Selected Summaries srr--Special Reports and Reviews t m i g - - T h i s Month in Gastroenterology vodd--Viewpoints on Digestive Diseases

hepatitis C virus and, 108:1104 hepatitis delta virus and, 108:623-tmig, 108:796 IFN-~ for chronic hepatitis B in HIV infection and, 108:l-tmig, 108:165 primary sclerosing cholangitis and, 108:1199 refrigerated donor livers and, i08:1510

1982

SUBJECT INDEX

small heparocellular carcinoma and, 108:768

Albumin anti-hydroxyethyl free radical-modified, 108:201 follistatin and (rat), 108:1136 primary sclerosing cholangitis and, 108:1199 radiation-induced microvascular dysfunction and (rat), 108:1761 small heparocellular carcinoma and, 108:768

Alcohol antibiotics block liver injury by (rat), 108:l-tmig, 108:218 heartburn and, 108:2-tmig, 108:125 liver cell necrosis and, 108:263-srr Alcohol dehydrogenase, cimetidine and (rat), 108:737 Alcoholic pancreatitis, progression of, 108:297-ss

Alcoholism anti-hydroxyethyl free radical-modified albumin and, 108:l-tmig, 108:201 hepatic mitochondrial DNA deletion in, 108:193 intestinal permeability and, 108:1574-srr liver transplantation and, 108:615-br UGT and, 108:1464

Alkaline phosphatase colchicine and, 108:1470 primary sclerosing cholangitis and, 108:1199 ursodeoxycholic acid and, 108:1470 Alkoxyl radicals, liver cell necrosis and, 108:257-srr Alkylation, anti-hydroxyethyl free radicals in alcoholic cirrhosis and, 108:201 A l l e r g y , intestinal permeability and, 108:1575-srr

¢~,-adrenerglc vasoconstriction, atrial natriuretic antagonism of (rat), 108:803 ot-fetopgotein, hepatocellular carcinoma and, I08:624-tmig, 108:768, 108:812, 108:1778 Ambulant subjects, gastroesophageal reflux mechanisms on, 108:83

American Gastroenterological Association American Gastroenterological Association medical position statement: guidelines for the use of enterai nutrition, 108:1280 American Gastroenterological Association technical review on tube feeding for enteral nutrition, 108:1282 Consensus conference statement: Escherichia coli O157:H7 infections--an

GASTROENTEROLOGY Vol. 108, No. 6

emerging national health crisis, July 11-13, 1994, 108:1923 Our new president--James W. Freston, M.D., Ph.D., 108:1339 Amiloride gastric mucosal pHi regulation and (Neetutus, 108:999 octreotide and (prairie dog), 108:1547 A m i n o acids CYP2D6 antigenic sites and, 108:470 genomic variations in precore/core gene of hepatitis B virus and, 108:310-tmig, 108:505 leakage of free, refrigerated donor livers and, 108:1337-tmig, 108:1510 transport of, 108:888-srr Aminophylline, colonic permeation of inulin and (rat), 108:12 A m i n o t e r m i n a l p r o p e p t i d e , type III procollagenm 108:1470

Aminotransferases colchicine and, 108:1470 ursodeoxycholic acid and, 108:1470 A m m o n i a , luminal, Helicobacter pylori and (rat), 108:309-tmig, 108:320 Ammonium acetate, dietary ammonium-induced hypergastrinemia and (rat), 108:309-tmig, 108:320 A m o x i c i l l i n , for Helicobacter pylori, 108:1338-tmig, 108:1412 A m p h i r e g u l i n , gastrointestinal pathophysiology and, 108:573-srr A m p u l l a of Vater, sphincter of Oddi dysfunction and, 108:242-cr A m p u l l a r y neoplasm, sphincter of Oddi dysfunction caused by, 108:242-cr

Amylase IL-10 in pancreatitis and, 108:1917-rc inhibition, carbohydrate digestion and (dog), 108:1221 liver development and, 108:1236 pancreatic cyst fluid analysis and, 108:958tmig, 108:1230 pancreatitis and (rat), 108:1855

Anal sphincter squeeze pressure, rectoanal inhibitory reflex and, 108:1700

Anemia genetic hemochromatosis and, 108:208 sulindac and, 108:1083

Aneuploidy achalasia-associated esophageal squamous cell carcinoma and, 108:545-cr colon cancer and, 108:1040 Angiogenesis inhibitor, pancreatic cancer and (Syrian hamster), 108:1526 Angiography, multiple focal nodular hyperplasia of liver and, 108:1256-cr

Angiostatin, metastatic suppression and, 108:1946-ss A n i m a l s , live, E. coli O157:H7 and, 108:1927-aga Anogectal function, spinal reflex control of, 108:990 Anorectal manometi'y, anorectal function and, 108:990 Anorexia, colonic sarcoidosis and, 108:1556-cr A n o x i c i n j u r y , liver cell necrosis and, 108:260-srr Anti-asialo GM1 anti7body, SF-25 monoclonal antibody and (nude mice), 108:172 Antibiotics, liver injury by alcohol blocked by (rat), 108:l-tmig, 108:218

Anti'bodies alcoholic cirrhosis and, 108:l-tmig, 108:201 carbonic anhydrase, 108:1615-tmig, 108:1802 CFTR (human, rat), 108:1016 chronic viral hepatitis and, 108:157 Crohn's disease and, 108:1338-tmig, 108:1396 cryptosporidiosis with AIDS and, 108:627 CYP2D6 antigenic sites and, 108:470 E. coli (rat), 108:1835 eosinophil migration and, 108:409 familial inflammatory bowel disease and, 108:428 HBeAg, 108:l-tmig, 108:165, 108:505 hepatitis B virus, 108:1810 hepatitis C virus, 108:581-rc hepatitis E virus, 108:l-tmig, 108:225 Hsp60 expression and, 108:73 immunostaining for membrane attack complex of complement and, 108:309-tmig, 108:495 inhibition of liver metastases of colon cancer and (nude mice), 108:172 oz6-integrin, 108:523 kinesin (rat), 108:824 £isteria, 108:1396 pyruvate dehydrogenase, 108:1802 radiation-induced microvascular dysfunction and (rat), 108:1761 TNF-c~, 108:761 UGT, 108:1464 ulcerative colitis and, 108:423, 108:597-e ZO-1 (rat), 108:1863

Antigens anti-hydroxyethyl free radicals in alcoholic cirrhosis and, 108:201 intestinal permeability in Crohn's disease and, 108:2-tmig, 108:132 Anti-inflammatory food, Crohn's disease and, 108:957-tmig, 108:1056

June 1995

Antinuclear antibodies, chronic viral hepatitis and, 108:157

Antineutrophil cytoplasmic antibodies (ANCA) autoimmune hepatitis and, 108:1159 familial inflammatory bowel disease and, 108:428 ulcerative colitis and, 108:423, 108:597-e

Antioxidants colon cancer and, 108:1322-ss liver cell necrosis and, 108:257-srr

(x,-Antitrypsin AIDS-related cryptosporidiosis and, 108:1075 childhood deficiency of, 108:1270-srr primary sclerosing cholangitis and, 108:1199 A n t r a l vascular ectasia, portal hypertensive gastropathy and, 108:138 Antrectomy, pancreastatin and (rat), 108:1445

Antroduodenal dysautonomia, acute, hyperglycemia and, 108:951-c

Antroduodenal manometry childhood chronic intestinal pseudo-obstruction and, 108:1379 hyperglycemia-evoked gastric slow-wave dysrhythmias and, 108:727

SUBJECT INDEX

A r t e r i a l p e r f u s i o n - f i x a t i o n , Crohn's disease and, 108:911-srr A r t e r i a l p r e s s u r e , homeostasis of, endothelin 1 and (rat), 108:1842 A r t e r i a l s u p p l y , multiple focal nodular byperplasia of liver and, 108:1256-cr Asacol, Crohn's disease and, 108:1936-e A s c a r i s l u m b r o i d e s , intestinal permeability and, 108:1574-srr Ascending contractions, glucose effects on colon motility and, 108:350 Ascites, cirrhosis with, 108:487, 108:1496, 108:1828, 108:1835, 108:1842 Asia, brown pigment gallstones and, 108:1337-tmig, 108:1534 Aspartame, behavior and cognitive performance affected by, 108:299-ss

Aspartate aminotransferase free radical production after cold storage and (rat), 108:1167 hepatic reperfusion injury and (rat), 108:463 liver injury by alcohol blocked by antibiotics (rat), 108:218 primary sclerosing cholangitis and, 108:1199 refrigerated donor livers and, 108:1510

Antrum

Aspiration

dietary ammonium-induced hypergastrinemia and (rat), 108:309-tmig, 108:320, hyperglycemia-evoked gastric slow-wave dysrhythmias and, 108:727 A n u s , surgery of, 108:301-br A o r t a , endothelin 1 and (rat), 108:1842 APC mutations, in colitis-associated neoplasias, 108:383 Apheresis, T-lymphocyte, in Crohn's disease, 108:952<

cytology, pyogenic granuloma in Barrett's esophagus and, 108:1894-cr deglutitive, tracheostomy and, 108:1357 tube feeding and, 108:1290-aga A s p i r i n , colon cancer risk and, 108:612-ss Atopic eczema, intestinal permeability and, 108:1575-srr ATPases, kinesin inhibition and (rat), 108:824 A t r i a , atrial natriuretic peptide in cirrhosis and (rat), 108:1496 A t r i a l n a t r i u r e t i c peptide (ANP) cirrhosis and (rat), 108:1496 as hepatic vasodilator (rat), 108:803 preascitic cirrhosis and, 108:1820

Apical membrane colonic, short-chain fatty acids and (rat), 108:673 esophageal, HCI and (rabbit), 108:662 Apnea, deglutitive, 108:1357 Apoptosis, phospholipids and, 108:304-c Aqueous paraceHular pathway, jejunal, flow rate and, 108:983 Arginine histamine ileal vasodilatory mechanisms and (guinea pig), 108:712 liver transport of, 108:898-srr NO in ethanol-induced gastric mucosal injury and (rat), 108:58 NO in primate colitis and (rhesus macaque), 108:705 NO synthase in portal hypertension and (rat), 108:1487 pancreatitis and (rat), 108:1855 A r t e r i a l blood volume, preascitic cirrhosis and, 108:1820

Autoantt~odies autoimmune hepatitis and, 108:1159 chronic viral hepatitis and, 108:157 microsomal, in viral hepatitis, 108:455 Autoimmune cholangitis, carbonic anhydrase antibodies and, 108:1615tmig, 108:1802 A u t o i m m u n e d i s e a s e s , Hsp60 expression and, 108:75 Autoimmune expression, chronic viral hepatitis and, 108:157

Autoimmune hepatitis carbonic anhydrase antibodies and, 108:1802 hepatitis C virus and, 108:1770, 108:1942-e interferon and, 108:1770, 108:1942-e

:!.983

type-l, ANCA in, 108:1159

Autophosphorylation, premalignant colon lesions and, 108:117

Autopsy, colorectal adenoma and, 108:402 Avidin-biotin complex method, coiorectal aberrant crypt loci and, 108:434 A z a t h i o p r i n e (AZT), Crohn's disease and, 108:1936-e

B7-positlve cells, Hsp60 expression and, 108:75

Bacteria cholesterol gallstones and, 108:624-tmig, 108:860, 108:934-e cirrhosis and, 108:1616-tmig, 108:1828 Crohn's disease and, 108:1396 epithelial cell proliferation and (mouse), 108:1745 Hsp60 expression and, 108:75 liver injury by alcohol blocked by antibiotics (rat), 108:l-tmig, 108:218 pneumatosis cystoides intestinalis and, 108:1560-cr Bacterial translocation, in cirrhosis (rat), 108:1835 B a c t e r o i d e s spp., dietary stimulation of bifodobacteria and, 108:958-tmig, 108:975 B a c t e r o i d e s v u l g a t u s , Crohn's disease and, 108:1396 Balilomycin, pancreatic H+/HCO3 - secretion and (pig), 108:850

Balloon distension esophageal sensitization in noncardiac pain and, 108:311 glucose effects on colon motility and, 108:309-tmig, 108:350 irritable bowei syndrome and, 108:636, 108:927-e rectoanal inhibitory reflex and, 108:1700 B a r i u m enema colonic sarcoidosis and, 108:1556-cr Crohn's disease and, 108:310-tmig, 108:345 HCI in esophageal ceils and (rabbit), 108:662 hereditary nonpolyposis colorectal cancer and, 108:1405

Barostat-regulated balloons glucose effects on colon motility and, 108:309-tmig, 108:350 gut distension and, 108:680

Barrett's esophagus pyogenic granuloma and, 108:1894 quantitative imaging of, 108:360

Basolateral membrane cystic fibrosis transmembrane conductance regulator and (rat, human), 108:1016 esophageal cell, HC1 and (rabbit), 108:662

1984

SUBJECT INDEX

B cells, intestinal permeability in Crohn's disease, 108:2-tmig, 108:132 Beer, heartburn and, 108:125 Behavior, diet and, 108:299-ss

Behavioral modification therapy, rumination syndrome and, 108:957tmig

Belch r e s p o n s e lower esophageal sphincter tone and, 108:441 rumination syndrome and, 108:957-tmig Bench, bedside and, 108:1343-e B-carotene, vitamin E enhances absorption of (ferret), 108:719 Betacellulin, gastrointestinal pathophysiology and, 108:574-srr Bethanecol, glucose effects on colon motility and, 108:350 Beverages, popular, heartburn and, 108:2-tmig, 108:125

Bicarbonate butyrate uptake and (rat), 108:673 carbonic anhydrase and, 108:102 duodenal secretion of, histamine and (rabbit), 108:1676 gastric mucosal phi regulation and (Necturus, 108:999 hepatocellular DNA synthesis and (rat), 108:477 pancreatic H+/HCO3 - secretion and (pig), 108:850 Bifidobacteria, dietary stimulation of, 108:958-tmig, 108:975

Bile brown pigment gallstones and, 108:1337tmig, 108:1534 canalicular contraction, nitric oxide blocks, 108:841 composition, gallbladder emptying and, 108:1615-tmig, 108:1882 6-fluoro-ursodeoxycholic acid analogue and, 108:1204 leukotriene C4 and (rat), 108:1793

Bile acids esophageal mucosal injury and, 108:1897srr inhibition of liver kinesin by (rat), 108:824 interferon cr and (rat), 108:1192 B i l e duct resection, opioid binding in cholestasis and (rat), 108:1479

Bile ducts carbonic anhydrase and, 108:1802 hilar intrahepatic, pancreatic enzymes and, 108:1236 B i l i a r y atresia, growth factors and, 108:145 B l l i a g y dilatation, sphincter of Oddi dysfunction and, 108:242-cr B i l i a g y fistula, cholesterol 7c~-hydroxyiase and (rat), 108:533

GASTROENTEROLOGY Vol. 108, No. 6

B i l i a r y t r a c t , surgery of, 108:1951-br Bilirubin colchicine and, 108:1470 monitoring, duodenogastric reflux and, 108:1903-srr primary sclerosing cholangitis and, 108:1199 utsodeoxycholic acid and, 108:1470 Billtec, duodenogastric reflux and, 108:1332-c, 108:1903-srr B i n d i n g proteins, IGF-1 and (rat), 108:644 Biogenic amines, midget carcinoid flush and, 108:743

Biopsy duodenal, genetic hemochromatosis and, 108:2-tmig, 108:208 Griisbeck-Imerslund disease and, 108:1622 Hsp60 expression and, 108:75 interleukin 10 in IBD and, 108:1434 liver hepatic iron concentration and, 108:1104 HIV-associated necrotizing cholangitis caused by Septata intestinalis and, 108:247-cr liver cell dysplasia and, 108:624-tmig, 108:812 multiple focal nodular hyperplasia of liver and, 108:1256-cr primary sclerosing cholangitis and, 108:1199 UGT and, 108:1464 Biotransformation, hepatic glucuronidation and (rat), 108:183 B i r c h p o l l e n o s i s , intestinal permeability and, 108:1576-srr

2'7'-bis(carboxyethyl)-5,6carboxyflnorescein, pancreatic H+/HCO3 secretion and (pig), 108:850 B l a c k s , colonic sarcoidosis and, 108:1556cr

Blebbing, liver cell necrosis and, 108:253srr

Bleeding cirrhotic, bacterial infection and, 108:1616-tmig, 108:1828 polycystic liver disease and, 108:487 Blenderized diets, role of, 108:1294aga Blood-brain b a r r i e r , quinolinic acid and, 108:818

B l o o d flow NO in ethanol-induced gastric mucosal injury and (rat), 108:58 pancreatic, nitric oxide and (cat), 108:1215 B l o o d loss, intestinal, antral vascular ectasia and, 108:138

B l o o d volume expansion, preascitic cirrhosis and, 108:1820

B N 5 2 0 2 1 , platelet-activating factor receptors and (guinea pig), 108:1666

B o d y position, gastroesophageal reflux in ambulant subjects and, 108:83

Boiling, interleukin 1/3 and (rat), 108:1720

B o l u s viscosity, tongue force modulation and, 108:1418

Bone disease, in cholestatic liver disease, 108:276-vodd metabolism, in inflammatory bowel disease, 108:417, 108:1607-c

B o o k Reviews Advanced Therapeutic Endoscopy, 2nd ed., 108:1951 Basic and Clinical Aspects of Chronic Abdominal Pain, 108:947 Color Atlas of Diagnostic Laparoscopy, 108:1604 Digestive Diseases in the United States: Epidemiology and Impact, 108:947 Diseases of the Gut and Pancreas, 108:615 Gastroenterology--Clinical Science and Practice, Volumes 1 and 2, 108:301-br Immunology and Inflammation of the Gastrointestinal Tract, 108:1327 Iron metabolism in health and disease, 108:1328 The Liver: Biology and Pathobiology, 3rd ed., 108:1603 Liver Transplantation and the Alcoholic Patient: Medical, Surgical, and Psychosocial Issues, 108:615 Pediatric Enteral Nutr#ion, 108:1603 Physiology of the Gastrointestinal Tract, 3rd ed., 2 volumes, 108:948 Principles and Practice of Gastroenterology and Hepatology, 2nd ed., 108:1327 Surgery of the Anus, Rectum, and Colon, Volumes 1 and 2, 108:301 Surgery of the Liver and Biliary Tract, 2nd ed., 108:1951 Borrelia burgdorferi, Crohn's disease and, 108:1396 Bovine virus diarrhea v i r u s , Crohn's disease and, 108:1396 B o w e l habit, dietary stimulation of bifodobacteria and, 108:975 B o w e l sounds, hyperactive, colonic sarcoidosis and, 108:1556-cr B o w e l transit t i m e , dietary stimulation of bifodobacteria and, 108:975 B Q - 1 2 3 , endothelin receptors and (guinea pig), 108:51 Brain edema, after hepatectomy rat), 108:1097 kinesin and (rat), 108:824 quinolinic acid and, 108:818

June 3.995

stress and, 108:618-c Wilson's disease and, 108:885-cr

Brain stem nitric oxide synthase in (rat), 108:367 pancreatic polypeptide and (rat), 108:1517 Breast feeding, intestinal permeability and, 108:1575-srr

Breath tests dietary stimulation of bifodobacteria and, 108:975 gastric emptying and, 108:957-tmig, 108:1048 Brefeldin A, cytochrome P4502B traffic and (rat), 108:1110 4-Bromobutyrate, in distal colonic apical membrane vesicles (rat), 108:673

8-Bromo-cyclic adenosine monop h o s p h a t e (Br-cAMP), secondary biliary cirrhosis and (rat), 108:1183

8-Bromo-cyclic g u a n o s i n e monop h o s p h a t e (Br-cGMP)

SUBJECT INDEX

Calcium cholangiocarcinoma and, 108:1908-rc metabolism, after myenteric denervation (rat), 108:1629 octreotide and (prairie dog), 108:1547 osteopenia and, 108:417 Calcium channel blockers, voltagedependent, hepatocellular DNA synthesis and (rat), 108:477 Campylobacterjejuni, gastric epithelium and, 108:65 Canalicular contraction, bile, nitric oxide blocks, 108:84I Cancer, intestinal permeability and, i08:1576-srr C a p i l l a r i z a t i o n , theophylline clearance and (rat), i08:1504 C a p s a i c i n , secondary biliary cirrhosis and (rat), 108:1183 Capsid primers, type-specific, HCV genotyping and, 108:1088

Carbachol

atrial natriuretic peptide in hepatic vasodilation and (rat), 108:803 bile canalicular contraction and, 108:841 cholera toxin and (rat), 108:34 B r o m o d e o x y u r i d i n e labeling, nuclear, follistatin and (rat), 108:1136 2-Bromopropionate, in distal colonic apical membrane vesicles (rat), 108:673 B r o w n p i g m e n t stones, liver disease and, 108:1337-tmig, 108:1534 B r u s h border membrane, cystic fibrosis transmembrane conductance regulator and (rat, human), 108:1016 B r u s h cytology, cholangiocarcinoma in primary sclerosing cholangitis and, 108:865 B u l i m i a , rumination syndrome and, 108:1024 Burn patients, intestinal permeability and, 108:1576-srr

colonic myoelectric complexes and (mouse), 108:1371 myenteric denervatim~ of jejunum and (rat), 108:1629 CarbamylchoHne, ileal crypts and (mouse), 108:1345 Carbohydrate antigen, pancreatic cyst fluid analysis and, 108:958-tmig, 108:1230

C 5 a , eosinophil migration and, 108:409

Carbon tetrachloride

Ca2+ hepatocellular DNA synthesis and (rat), 108:477 ileal crypts and (mouse), 108:i345 InsP3 release of, bile canalicular contractions and, 108:841 Ca2+-ATPase, myenteric denervation of jejunum and (rat), 108:1629 Caco-2 c e l l s , monocyte-chemoattractant protein 1 and, 108:40 C a f f e i n e , cytochrome P4502B traffic and (rat), 108:1110

Calcitonin gene-related peptlde ( C G R P ) , secondary biliary cirrhosis and (rat), 108:1183

Carbohydrate antigen 19-9 (CA199), cholangiocarcinoma in primary sclerosing cholangitis and, 108:865

Carbohydrate dietary stimulation of bifodobacteria and, 108:958-tmig, 108:975 digestion, amylase inhibition and (dog), 108:1221 Carbon dioxide (COa), HCI in esophageal ceils and (rabbit), 108:662

Carbonic anhydrase autoimmune cholangitis and, 108:1615tmig, 108:1802 duodenal HCO 3- secretion and, 108:102 atrial natriuretic peptide in cirrhosis and (rat), 108:1496 soluble TNF-o! receptor and (rat), 108:1616-tmig, 108:1849 Carbowax, intestinal permeability and, 108:1568-srr Carboxyterminal propeptide, type I procollagen, 108:1470

Carcinoembryonic antigen (CEA) cholangiocarcinoma in primary sclerosing cholangitis and, 108:865 pancreatic cyst fluid analysis and, 108:958tmig, 108:1230

Carcinoids gastric, management of, 108:296-ss

3.985

midget, 108:743

Cardiac ultrasonography, atrial natriuretic peptide in cirrhosis and (rat), 108:1496 Cardiopulmtonary bypass, intestinal permeability and, 108:1576-srr Cardiorespiratory parameters, conscious sedation for gastroscopy and, 108:697, 108:932-e CalTageenan, SF-25 monoclonal antibody and (nude mice), 108:172

Case Reports Achalasia-associated squamous cell carcinoma of the esophagus: flow-cytometric and histologicai evaluation, 108:545 Colonic obstruction secondary to sarcoidosis: nonsurgicaI diagnosis and management, 108:1556 Copper-induced acute rhabdomyolysis in Wilson's disease, 108:885 Exacerbation of chronic ulcerative colitis with mesalamine, 108:1889 Giutaraldehyde colitis foUowing endoscopy: clinical and pathological features and investigation of an outbreak, 108:1250 Human immunodeficiency virus 1-associated necrotizing cholangitis caused by infection with Septata h~testinalis, 108:247 Human papillomavirus type 16-positive esophageal papilloma at an endoscopic injection sclerotherapy site, 108:550 Multiple focal nodular hyperplasia of the liver associated with hemihypertrophy and vascular malformations, 108:i256 Orthotopic liver transplantation for chronic hepatitis in two patients with common variable immunodeficiency, 108:879 The pancreas as a site of granulomatous inflammation in Crohn's disease, 108:1246 Pneumatosis cystoides intestinalis and high breath H2 excretion: insights into the role of Hz in this condition, 108:1560 Pyogenic granuloma in Barrett's esophagus mimicking esophageal carcinoma, 108:1894 Sphincter of Oddi dysfunction caused by an ampullary neoplasm, i08:242

Catecholamines ileal crypts and (mouse), 108:1345 midget carcinoid flush and, 108:743 Cation exchange resin, in fecal Na + and K + excretion, 108:752 Cattle, E. coli O157:H7 and, 108:1927-aga

1986

SUBJECT INDEX

CD4 +, cryptosporidiosis with AIDS and, 108:624-tmig C D l l , eosinophil migration and, 108:409 C D l l b / C D 1 8 , Helicobacterpylori infection and, 108:65 CD18, radiation-induced microvascular dysfunction, and (rat), 108:1761 C D 1 9 + B c e l l s , intestinal permeability in Crohn's disease and, 108:132 CD45RO, intestinal permeability in Crohn's disease and, 108:2-tmig, 108:132 C D 5 4 , Helicobacterpylori infection and, 108:65

Cecum bacterial translocation and (rat), 108:1835 circular smooth muscle ceils, endothelin receptors on (guinea pig), 108:51 dexamethasone-/5-D-glucuronide and (rat), 108:1688 epithelial cell proliferation and (mouse), 108:1745

Celiac d i s e a s e intestinal permeability and, 108:1574-srr serological screening of, 108:608-ss Ceil a d h e s i o n m o l e c u l e s , in chronic viral hepatitis, 108:231 C e l l c o n t r a c t i o n , platelet-activating factor receptors and (guinea pig), 108:1666 Cell-mediated i m m u n i t y , SF-25 monoclonal antibody and (nude mice), 108:172 C e l l m i g r a t i o n , human spasmolytic polypeptide and, 108:108 C e l l n u c l e a r a n t i g e n l a b e l i n g ind e x , small heparocellular carcinoma and, 108:768 Cellobiose, intestinal permeability and, 108:1569-srr C e i l p r o l i f e r a t i o n , fermentable dietary fiber and (mouse), 108:1745 Cell surface antigen, in colon adenocarcinoma (nude mice), 108:172 C e l l u l a r t r a f f i c k i n g , cytochrome P4502B and (rat), 108:1110 Cerebral cortex, edematous, after hepatectomy rat), 108:1097

Cerulein IL-10 in pancreatitis and, 108:1917-rc nitric oxide and (rat), 108:1855 pancreatitis and (rat), 108:1855, 108:1863 C e r u l o p l a s m i n , primary sclerosing cholangitis and, 108:1199 C e r v i x , papilloma-carcinoma sequence in, 108:550-cr C e t r i m i d e , intestinal permeability and, 108:1574-srr CF-IBE c e l l s , complementation of cystic fibrosis defect in, 108:584-rc

GASTROENTEROLOGY Vol. 108, No. 6

CH4 b r e a t h test, dietary stimulation of bifodobacteria and, 108:975 C h e m i c a l c o d i n g , enteric inhibitory neurons and, 108:556-srr C h e m i c a l s t i m u l u s , esophageal sensitization in noncardiac pain and, 108:311

Chemiluminescence free radical production after cold storage and (rat), 108:1167 hepatic reperfusion injury and (rat), 108:463

Chemotaxis eosinophil migration and, 108:409 monocyte-chemoattractant protein 1 and, 108:40

Chemotherapy infection in bleeding cirrhotic patients and, 108:1828 intestinal permeability and, 108:1576-srr photodynamic therapy for esophageal cancer and, 108:310-tmig C h e n o d e o x y c h o l a t e , kinesin inhibition by (rat), 108:824

C h e n o d e o x y c h o l i c acid colonic permeation of inulin and (rat), 108:12 intestinal permeability and, 108:1576-srr Chest p a i n , mesalamine and, 108:1889cr Chief c e l l s , gastric, pepsinogen secretion and (guinea pig), 108:1709

Child-Pugh s c o r e antral vascular ectasia and, 108:138 infection in bleeding cirrhotic patients and, 108:1828

Children allergy in, 108:1575-srr al-antitrypsin deficiency in, 108:1270-srr behavior and cognitive performance affected by diet, 108:299-ss chronic intestinal pseudo-obstruction in, 108:1379 Crohn's disease in, 108:957-tmig eczema in, 108:1575-srr enteral nutrition in, 108:1603-br food intolerance in, 108:1575-srr Gaucher's disease in, 108:1266-srr hereditary tyrosinemia in, 108:1263-srr intestinal permeability in, 108:1575-srr metabolic liver disease in, 108:1263-srr recurrent syndrome in, 108:1576-srr Wilson's disease in, 108:1268-srr

Cholangiocarcinoma in primary sclerosing cholangitis, serum tumor markers for, 108:865 somatosatin receptors and, 108:1908-rc

Cholangitis autoimmune, carbonic anhydrase antibodies and, 108:1615-tmig, 108:1802

HIV-associated, Septata intestinalis in, 108:247-cr Cholate, kinesin inhibition by (rat), 108:824 C h o l e c y s t e c t o m y , gallbladder motility and, 108:1332<

C h o l e c y s t o k i n i n (CCK) amylase inhibition and (dog), 108:1221 antagonists, selectiveness of (dog), 108:1953 galanin receptors and (dog, guinea pig), 108:3 ileal crypts and (mouse), 108:1345 intestinal permeability and, 108:1576-srr nitric oxide and (cat), 108:1215 pancreatic polypeptide and (rat), 108:1517 C h o l e d o c h o l i t h i a s i s , magnetic resonance cholangiography and, 108:1948-ss

Cholera t o x i n distant secretion and (rat), 108:2-tmig, 108:34 nerves and, 108:287-e neurogenic inflammation in intestine and (rat), 108:295-ss

Cholestasis extrahepatic, Crohn's disease and, 108:1246-cr interferon c~ and (rat), 108:1192 leukotriene C4 synthesis and (rat), 108:1793 pruritis and, 108:1582-vodd WBC opioid binding and (rat), 108:1479 Cholestatic bile acids, inhibition of liver kinesin by (rat), 108:824

Cholestatic liver d i s e a s e bone disease in, 108:276-vodd 6-fluoro-ursodeoxycholic acid analogue and, 108:1204 liver cell necrosis and, 108:265-srr

Cholesterol colchicine and, 108:1470 esters, HepG2 ceils and, 108:515 gallstones bacterial colonization of, 108:624-tmig, 108:860, 108:934-e brown pigment in, 108:1337-tmig, 108:1334 nucleation of cholesterol crystals and, 108:1882 ursodeoxycholic acid and, 108:1470

C h o l e s t e r o l 7(x-hydroxylase liver disease and, 108:1337-tmig, 108:1534 taurocholate and (rat), 108:533 Choline, pancreatic H+/HCO3 secretion and (pig), 108:850

Cholinergic n e r v e s colonic myoelectric complexes and (mouse), 108:1371

June 1995

glucose effects on colon motility and, 108:310-tmig Chromatography, kinesin inhibition and (rat), 108:824 Chromogranin peptides, ECL cells and (rat), 108:1445

Chronic intestinal pseudo-obstruction, childhood, jejunal feeding in, 108:1379

Cimetidine gastric ethanol metabolism and (rat), 108:737 histamine in duodenal bicarbonate secretion and (rabbit), 108:1676 Ciprofloxacin, Crohn's disease and, 108:1936-e

Cirrhosis anti-hydroxyethyl free radical-modified albumin and, 108:l-tmig, 108:201 antrai vascular ectasia and, 108:138 atrial natriuretic peptide and (rat), 108:1496 bacteria and, 108:1616-tmig, 108:1828 bacterial translocation and (rat), 108:1835 changing prevalence of HCV genotypes and, 108:581-rc endothelin 1 and (rat), 108:1842 gastric microcirculation and (rat), 108:1183 genomic variations in precore/core gene of hepatitis B virus and, 108:505 hepatic arterial resistance in, 108:1152 hepatic mitochondrial DNA deletion in alcoholics and, 108:193 hepatitis C virus genotyping and, 108:1088 in hepatocellular carcinoma, liver cell dysplasia as risk factor for, 108:624tmig, 108:812 intestinal permeability and, 108:1576-srr NO synthase in portal hypertension and (rat), 108:1487 oxygen supplementation and (rat), 108:1504 portal hypertensive gastropathy and, 108:138 preascitic, sodium handling and, 108:1820 small heparocellular carcinoma and, 108:768 theophylline and (rat), 108:1504 TIPS and, 108:958-tmig UGT and, 108:1464 Citrate, intestinal permeability and, 108:i573-srr

Citrulline NO in primate colitis and (rhesus macaque), 108:705 NO synthase in portal hypertension and (rat), 108:1487 Citrus drinks and juices, heartburn and, 108:2-tmig, 108:125

SUBJECT INDEX

CIcryptosporidiosis and (piglet), 108:1030 flux, octreotide and (prairie dog), 108:1547

Clamping glucose effects on colon motility and, 108:350 hyperglycemia-evoked gastric slow-wave dysrhythmias and, 108:727 rectoanal inhibitory reflex and, 108:1700 Clostridia, dietary stimulation of bifodobacteria and, 108:961-tmig, 108:975

Clostridium difficile colonization of cholesterol gallstones and, 108:861 neurogenic inflammation in intestine and (rat), 108:295-ss Clotting-llke process, fibrinogen and (rat), 108:1124 1 3 C 0 2 exhalation, {I3C]acetate breath test for gastric emptying and, 108:1048 Coagulation disorders, inherited, inflammatory bowel disease and, 108:1011, 108:1305-e Cobalamin, Gr~sbeck-Imerslund disease and, 108:1622 Coffee, heartburn and, 108:2-tmig, 108:125 Cognitive performance, diet and, 108:299-ss C o i n f e c t i o n , HIV and chronic hepatitis B virus, 108:l-tmig, 108:165

Colchlcine cytochrome P4502B traffic and (rat), 108:1110 primary biliary cirrhosis and, 108:1470, 108:1592-e primary sclerosing cholangitis and, 108:1199 Cold ischemia, refrigerated donor livers and, 108:1337-tmig, 108:1510

Cold storage hepatic free radical production after (rat), 108:1167, 108:1317-e refrigerated donor livers and, 108:1337tmig, 108:1510

CoHtis APC and K-ras in neoplasias with,

108:383 glutaraldehyde, after endoscopy, 108:1250-cr IGF-1 and (at), 108:644 primate, nitric oxide and (rhesus macaque), 108:705 Collagen gel invasion assay, human spasmolytic polypeptide and, 108:108

Colon adenoma, c-yes tyrosine kinase activity in, 108:117, 108:29l-e

1987

cancer aberrant crypt loci and, 108:434, 108:600-e, 108:i609-c antioxidants and, 108:1322-ss aspirin vs colonoscopy in reduction of, 108:612-ss gastrin and, 108:618-c, 108:1068, 108:1307-e hereditary nonpolyposis, 108:1337tmig, 108:1405, 108:1590-e human spasmolytic polypeptide and, i08:108 inhibition of hepatic metastases and (nude mice), 108:172 intestinal permeability and, 108:1576srr K-ras and, 108:434, 108:600-e, 108:1040 NSAIDs and, 108:1310-e p53 protein and, 108:434 plasminogen activation system and, 108:1953< ulcerative colitis and, 108:1321-ss dexamethasone-/3-b-glucuronide and (rat), 108:1688 distal, short-chain fatty acids and (rat), 108:673 electrolytes, cholera toxin and (rat), 108:2tmig, 108:34 epithelial ceil proliferation and (mouse), 108:1745 Hsp60 expression and, 108:75 malignant polyps and, 108:1615-tmig, 108:1657 mesalamine microgranule delivery in, 108:1338-cmig, 108:1427 motility, hyperglycemia and, 108:309tmig, 108:350 motor patterns, sleep neurobiology and, 108:1609-c myoelectric complexes, neural control of (mouse), 108:I371 obstruction, secondary to sarcoidosis, 108:1556-ct papilloma-carcinoma sequence in, 108:550-cr permeation, inulin and (rat), 108:12 pneumatosis cystoides intestinalis and, 108:1560-cr sporadic polyps, sulindac and, 108:1083, 108:1311-e surgery of, 108:301-br transforming growth factor c~ in, 108:371srr

Colonoscopy colon cancer risk and, 108:612-ss colonic sarcoidosis and, 108:1556-cr colorectal adenoma and, 108:309-tmig, 108:402 hereditary nonpolyposis colorecral cancer and, 108:1337-tmig, 108:1405

1988

SUBJECT INDEX

sulindac and, 108:1083 Coloproctectomy, osteopenia and, 108:417

Colorectal adenoma incidence and recurrence, 108:309-tmig, 108:402 K-ras-2 mutations in, 108:1040 sporadic, NSAIDs and, 108:1310-e

'Common' 4977-base pair deletion, in hepatic mitochondrial DNA of alcoholics, 108:193 Common leukocyte antigen, intestinal permeability in Crohn's disease and, 108:132

Common variable immunodeficiency ( C V I D ) , chronic hepatitis with, liver transplantation for, 108:879-cr Complement activation, membrane attack complex and, 108:309-tmig, 108:495

Complement inhEbitory proteins, immunostaining for membrane attack complex of complement and, 108:495 Compliance, sulindac and, 108:1083

Computed tomography (CT) cholangiocarcinoma in primary sclerosing cholangitis and, 108:865 HIV-associated necrotizing cholangitis caused by Septata intestinalis and, 108:247-cr multiple focal nodular hyperplasia of liver and, 108:1256-cr pancreatic cyst fluid analysis and, 108:958tmig polycystic liver disease and, 108:487 C o n f o c a l m i c r o s c o p y , cytochrome P4502B traffic and (rat), 108:1110 Conformational epitopes, on CYP2D6, 108:470 Conscious sedation, for gastroscopy, 108:697, 108:932-e

Constipation colonic sarcoidosis and, 108:1556-cr glucose effects on colon motility and, 108:309-tmig, 108:350 Contamination, hepatitis E virus infection and, 108:225

Continuous drip jejunal feeding, childhood chronic intestinal pseudoobstruction and, 108:1379 Contraction, galanin receptors and (dog, guinea pig), 108:3

Copper liver cell necrosis and, 108:264-srr rhabdomyolisis induced by, 108:885-cr Coproantibodies, cryptosporidiosis with AIDS and, 108:627 Core protein, genomic variations in pre-

GASTROENTEROLOGY Vol. 108, No. 6

core/core gene of hepatitis B virus and, 108:505 Correctol, in fecal Na + and K + excretion, 108:752

Correspondence Acute antroduodenal dysautonomia with hyperglycemia, 108:951 Bilitec to quantitate duodenogastric reflux: is it valid? 108:1332 Can we justify to resect all gastric epithelial dysplastic lesions? 108:1955 Cellular immune reactions against hepatitis C core in chronic hepatitis C, 108:1957 Correction, 108:954, 108:1334 Defective denominators, or will people never learn? 108:1963 Determinants of bone density in inflammatory bowel disease, 108:1607 Duplicate publication: additional comments, 108:950 Economic heartburn: average cost-effectiveness and gastroesophageal reflux disease, 108:303 Effect of cholecystostomy on gallbladder motility, 108:1332 Endoscopy--dollars and sense, 108:1957 Epidermal growth factor and intestinal growth, 108:1330 Ghosts in the stomach: may dead cells protect living ones? 108:304 The gold standard for assessing symptom associations, 108:1959 How selective are the cholecystokinin antagonists in the dog? 108:1953 Human papillomavirus and esophageal squamous cell carcinoma, 108:1605 Interventional radiology at the crossroads, 108:951 Is aberrant abnormal? 108:1609 Low-grade dysplasia in ulcerative colitis, 108:1610 Neurobiology of relaxation training in gastroesophageal reflux disease, 108:619 Neurobiology of sleep and human colonic motor patterns, 108:1609 No study is an island: muscarinic control of gallbladder revisited, 108:1329 Plasminogen activation system and colorectal cancer biology, 108:1953 Prognosis in nonalcoholic steatohepatitis, 108:1607 Prospective studies of the mucosa of the ileoanal pouch, 108:953 The reasons for ineffectiveness of H2-receptor antagonists in gastroesophageal reflux disease, 108:1958 Regulation of hepatocellular Na+/H + exchange, 108:305 Serum gastrin levels and colorectal neoplasia, 108:618

A simplified staging system for hepatocellular carcinomas, 108:617 Smoking and the gastric mucosa: some additional data, 108:1329 Stress--the brain and the gut, 108:618 Tempest about T-lymphocyte apheresis in Crohn's disease, 108:952 Treatment of refractory anorectal variceal bleeding, 108:1332 The use of gastrografin for esophageal perforation, 108:618 The use of glutamine in parenteral nutrition, 108:1961 Use of TIPS for refractory, not routine, variceal hemorrhage, 108:954 Corticosteroids, for Crohn's disease and, 108:417, 108:957-tmig, 108:1056 Corticosterone, dexamethasone-/3-Dglucuronide and (rat), 108:1688

Cost-effectiveness analysis endoscopy and, 108:1957-c gastroesophageal reflux disease and, 108:303-c home parenteral nutrition and, 108: 1303-e Cow's m i l k a l l e r g y , intestinal permeability and, 108:1575-srr

Cox's proportional hazaed model, small heparocellular carcinoma and, 108:768 C P - 9 6 , 3 4 5 , neurogenic inflammation in intestine and (rat), 108:295-ss 51Cr-EDTA, intestinal permeability and, 108:1569-srr cripto gene, gastrointestinal pathophysiology and, 108:575-srr

Crohn's disease bacteria and, 108:1396, 108:1589-e dexamethasone-/3-D-glucuronideand (rat), 108:1688 Hsp60 expression and, 108:75 intestinal permeability and, 108:2-tmig, 108:132, 108:1573-srr Listeria monocytogenes and, 108:1396, 108:1337-tmig, 108:1589-e measles virus infection and, 108:623-tmig, 108:911-srr, 108:1396 mesalamine for, 108:310-tmig, 108:345, 108:1338-tmig, 108:1427 meta-analysis of enteral feeding in, 108:957-tmig, i08:1056 metronidazole and, 108:1615-tmig, 108:1617, 108:1935-e monocyte-chemoattractant protein 1 and, 108:40 osreopenia and, 108:417 pancreas and, 108:1246-cr scanning-electron micriscopic lesions and, 108:376 smoking and, 108:1683

June 1995

Streptococcus spp. and, 108:1338-tmig, 108:1396 T-lymphocyte apheresis and, 108:952-c Cromolyn sodium, ulcerative colitis and, 108:1889-cr Crypt abcesses, NO in primate colitis and (rhesus macaque), 108:705 Crypt epithelial cells~ cystic fibrosis transmembrane conductance regulator and (rat, human), 108:1016

Cryptosporidiosis intestinal function and, 108:957-tmig, 108:1075 intestinal permeability and, 108:1030, 108:1575-srr mucosal immunity to, I08:624-tmig, 108:627 Cryptosporidium p a r v u m , cryptosporidiosis and (piglet), 108:1030 C g y s t a l s , cholesterol, nucleation of, 108:1882 Cutaneous nociceptors, esophageal sensitization in noncardiac pain and, 108:311 Cutaneous photosensitization, after photodynamic therapy for esophageal cancer, 108:337

Cyclic adenosine monophosphate (cAMP) CF-IBE cells and, i08:584-rc cholangiocarcinoma and, 108:1908-rc cholera toxin and, 108:2-tmig colonic permeation of inulin and (rat), 108:12

Cyclic guanosine monophosphate (cGMP) atrial natriuretic peptide in hepatic vasodilation and (rat), 108:803 nitric oxide and, 108:841 C y c l o h e x l m i d e , cytochrome P4502B traffic and (rat), 108:1110

Cyclooxygenases colon cancer and, 108:1312-e intestinal permeability and, 108:1573-srr Cyclopiazonic acid, myenteric denervation of jejunum and (rat), 108:1629

Cyclosporine Crohn's disease and, 108:1936-e inflammatory bowel disease and, 108: 943-ss c-yes oncogene, premalignant colon lesions and, 108:117, 108:291-e C Y P 2 D 6 , conformational epitopes on, 108:470 Cysteine, refrigerated donor livers and, 108:1510 Cysteinyl leukotrienes, bile transport and (rat), 108:1793

Cystic fibrosis defect, complementation of in biliary ceils, 108:584-rc

SUBJECT INDEX

intestinal permeability and, 108:1576-srr

Cystic fibrosis transmembrane conductance regulator (CFTR), intestinal villus expression of (human, rat), 108:1016 Cystoadenomas, pancreatic cyst fluid analysis and, 108:958-tmig, 108:1230

Cysts

1989

7-Dehydroxylation, 6-fluoro-ursodeoxycholic acid analogue and, 108:1204

O-Demethylation, CYP2D6 antigenic sites and, 108:470

Dendritic c e l l s , portal, VCAM-1 in chronic viral hepatitis and, 108:231

Denegvation, myenteric, calcium metabolism and (rat), 108:1629

2-Deoxy*D-glucose, pancreatic polypep-

fenestration, in polycystic liver disease, 108:309-tmig, 108:487 pancreatic, fluid analysis and, 108:958tmig, 108:1230 Cytochrome P 4 5 0 , UGT and, 108:1464 Cytochrome P 4 5 0 2 B , cellular trafficking and (rat), 108:1110 Cytochrome P 4 5 0 2 D 6 , microsomal autoantibodies in viral hepatitis and, 108:455 Cytochrome P 4 5 0 2 E 1 , hydroxyethyl free radicals and, 108:201 C y t o k e r a t i n , immunostaining for membrane attack complex of complement and, 108:495

Cytokines bile canalicular contraction and, 108:841 Helicobacterpylori infection and, 108:65 inflammatory bowel disease and, 108:21, 108:284-e, 108:1338-tmig, 108:1434 liver injury by alcohol blocked by antibiotics (rat), 108:l-tmig smooth muscle ceils and (rat), 108:1720

Cytolytic membrane attack complex, in hepatitis, 108:495 Cytoprotection assay, epidermal growth factor stability in gastric juice and, 108:92 ghosts of dead cells and, 108:304-c human spasmolytic polypeptide and, 108:108 C y t o s i n e , bacterial colonization of cholesterol gallstones and, 108:860 Cytosol, ileal crypts and (mouse), 108:1345 Cytotoxlc drugs, intestinal permeability and, 108:1576-srr

db/db mice d, GI tract endocrine cells and, 108:967

Decay-accelerating factor, immunostaining for membrane attack complex of complement and, 108:495

Defecation rectoanal inhibitory reflex and, 108:1700 reflex, 108:990 Deglutltion, tongue force modulation and, 108:1418 Deglutitive aspiration, tracheostomy and, 108:1357

tide and (rat), 108:1517

Depolarization colonic myoelectric complexes and (mouse), 108:1371 membrane, HCI in esophageal cells and (rabbit), 108:662 Dermatitis herpetiformis, intestinal permeability and, 108:1573-srr Detergency, 6-fluoro-ursodeoxycholic acid analogue and, 108:1204 Detoxification, hepatic glucuronidation and (rat), 108:183 Devascularization, brain edema and (rat), 108:1097 Developing countries, viremia in hepatitis E infection and, 108:l-tmig, 108:225

Development amino acid transport and, 108:902-srr liver, pancreatic enzymes in, 108:1236

Dexamethasone monocyte-chemoartractant protein 1 and, 108:40 NO synthase in portal hypertension and (rat), 108:1487 polymorphonuclear leukocyte margination and (rat), 108:393

Dexamethasone-/3-D-glucuronide, colitis and (rat), 108:1688

Dextrans~ intestinal permeability and, 108:1569-srr

Dextromethorphan, CYP2D6 antigenic sites and, 108:470

Diabetes amino acid transport and, 108:903-srr amylase inhibition and (dog), 108:1221 db/db mice and, 108:967 glucose effects on colon motility and, 108:309-tmig, 108:350 intestinal permeability and, 108:1576-srr Diabetic gastroparesis, hyperglycemia-evoked gastric slow-wave dysrhythmias and, 108:624-tmig, 108:727

4,6-Diamidino-2 -phenilindole-2hydrochloride, K-ras-2 mutations in colon cancer and, 108:1040

Diarrhea AIDS-related cryptosporidiosis and, 108:957-tmig, 108:1075 cholera toxin and (rat), 108:2-tmig, 108:34

1990

SUBJECT INDEX

Crohn's disease and, 108:1396 cryptosporidiosis and (piglet), 108:1030 fecal consistency and, 108:1729 HIV-associated, octreotide and, 108:1616tmig, 108:1753, 108:1939-e tube feeding and, 108:1292-aga

Dibutyryl adenosine 5'-cyclic adenosine monophosphate, colonic permeation of inulin and (rat), 108:12 Diene conjugation, liver cell necrosis and, 108:257-srr

Diet ammonium-induced hypergastrinemia and (rat), 108:309-tmig, 108:320 behavior and, 108:299-ss cognitive performance and, 108:299-ss Dietary adaptation, amino acid transport and, 108:902-srr Digestive diseases, in United States, 108:947-br 1,15-Dihydroxywitamin D3, osteopenia and, 108:417

4,4'-Diisothiocyanato-stilbene2,2'-disulfonic acid hepatic glncuronidation and (rat), 108:183 octreotide and (prairie dog), 108:1547 pancreatic H+/HCO3 - secretion and (pig), 108:850 D i m a p r i t , histamine in duodenal bicarbonate secretion and (rabbit), 108:I676

16,16-Dimethyl prostaglandin E2, colonic permeation of inulin and (rat), 108:12 Diphenoxylate, HIV-associated diarrhea and, 108:1940-e

Diploidy achalasia-associated esophageal squamous cell carcinoma and, 108:545-cr colon cancer and, 108:1040 Distal relaxation, glucose effects on colon motility and, 108:350 Distant secretion, cholera toxin and (rat), 108:2-tmig, 108:34

Distension abdominal, colonic sarcoidosis and, 108:1556-cr gastric tone and, 108:330 gut irritable bowel syndrome and, 108:636, 108:927-e sympathetic nervous system and, 108:680 painful, sensitization to, 108:311 DNA content heterogeneity, colon cancer and, 108:1040 DNA mutations, hereditary nonpolyposis colorectal cancer and, 108:1337tmig, 108:1405

DNA ploidy

GASTROENTEROLOGY Vol. 108, No. 6

achalasia-associated esophageal squamous cell carcinoma and, 108:545-cr colon cancer and, 108:1040 DNA synthesis, hepatocellular (rat), 108:477

gastric, 108:1955-c liver cell, 108:624-tmig, 108:812 premalignant colon lesions and, 108:117 ulcerative colitis and, 108:1361, 108:1610-c

Doppler ultrasonography hepatic arterial resistance and, 108:1152 TIPS and, 108:1143 Dorsal motor nucleus, pancreatic polypeptide microinjection into (rat), 108:1517

Dual energy X-ray absorptiometry,

Eczema, intestinal permeability and, 108:1575-srr

Edema brain, after hepatectomy rat), 108:1097 IL-10 in pancreatitis and, 108:1917-rc

osteopenia and, 108:417

Ductal drainage, sphincter of Oddi dysfunction and, 108:242-cr Ductular c e l l s , liver disease and, 108:145

Ductular proliferation colchicine and, 108:1470 ursodeoxycholic acid and, 108:1470 Dukes' classification, hypergastrihernia in colon cancer and (rat), 108:1068 Dnntmy receptor, carbon tetrachloride injury and (rat), 108:1616-tmig, 108:1849

Duodenogastric reflux Bilitec and, 108:1332-c esophageal mucosal injury and, 108:1897srr

Duodenum AIDS-related cryptosporidiosis and, 108:624-tmig, 108:627, 108:1075 bicarbonate secretion, histamine and (rabbit), 108:1676 Crohn's disease and, 108:1246-cr distension, sympathetic nervous system in, 108:680 genetic hemochromatosis and, 108:1tmig, 108:208 HCO3- secretion and, 108:102 hyperglycemia and, 108:951-c mesalamine microgranule delivery in, 108:1427 proximal, dietary ammonium-induced hypergastrinemia and (rat), 108:320 ulcers, Helicobacterpylori and, 108:1338tmig, 108:1412 Zollinger-Ellison syndrome and, 108:1637 Duplicate publication, additional comments, 108:950< Dynein, kinesin inhibition and (rat), 108:824 Dysautonomia, antroduodenal, hyperglycemia and, 108:951-c

Dyspepsia [13]acetate breath test for gastric emptying and, 108:i048 endoscopy and, 108:1324-ss

Dysplasia achalasia-associated esophageal squamous cell carcinoma and, 108:545-cr

Editorials Aberrant crypt foci and K-ras mutations: earliest recognized players or innocent bystanders in colon carcinogenesis? 108:600 Aggressive polyps in hereditary nonpolyposis colorectal cancer: targets for screening, 108:1590 Ambulatory recording of lower esophageal sphincter pressure: adding the missing link, 108:289 Autoimmune hepatitis and chronic hepatitis C: latent or initiated by interferon therapy?, 108:1942 Bacteria and cholesterol gallstones: molecular biology comes to gallstone pathogenesis, 108:934 Can incoagulable blood protect against inflammatory bowel disease, 108:1305 Colchicine and ursodeoxycholic acid for primary biliary cirrhosis: emerging results, 108:1592 The delicate balance of nitric oxide and superoxide in liver pathology, 108:603 Does HLA status influence prognosis in primary sclerosing cholangitis? 108:937 Evaluating a mature technology: longterm home parenteral nutrition, 108:1302 Fatty acid ethyl esters: insight or intoxication?, 108:605 Gastrin and colorectal cancer: a never-ending dispute?, 108:1307 GASTROENTEROLOGY:an international journal, 108:625 Gut feelings: what turns them on? 108:927 Hepatitis C after liver transplantation, 108:1314 HLA, antineutrophil cytoplasmic antibody, and heterogeneity in ulcerative colitis, 108:597 Interleukin-4 hyporesponsiveness in inflammatory bowel disease: immune defect or physiological response? 108:284

June •995

SUBJECT INDEX

Listeria: the latest putative pathogenetic

EndogHn, VCAM-1 in chronic viral hepa-

microorganism in Crohn's disease, 108:1589 The many facets of reperfusion injury, 108:1317 Nerves and cholera secretion, 108:287 Nonsteroidal anti-inflammatory drug use and sporadic colorectal adenomas, 108:1310 Octreotide therapy of human immunodeficiency virus-associated diarrhea: pitfalls in drug development, 108:1939 Photodynamic therapy for early esophageal cancers: light versus surgical might, 108:593 The prevention of Crohn's disease after surgery: metronidazole is a small but continuous medical advancement, 108:1935 Is proteolysis a critical mechanism of hepatic preservation injury? 108:1594 Sedation and analgesia for endoscopy, 108:932 Src family of tyrosine kinases: a role of cyea" in colon carcinogenesis?, 108:291 Too much bench, not enough bedside? 108:1343

titis and, 108:231 Endomysium, intestinal permeability and, 108:1573-srr

Educational strategies,

E. col~

O157:H7 and, 108:1928-aga Efferent neurons, rectoanal inhibitory reflex and, 108:1700 Elderly, pneumatosis cystoides intestinalis in, 108:1560-cr E l e c t r i c a l s t i m u l a t i o n , esophageal sensitization in noncardiac pain and, 108:311 Electrogastrography, hyperglycemiaevoked gastric slow-wave dysrhythmias and, 108:727 Electrolytes, colonic transport of, cholera toxin and (rat), 108:2-tmig, 108:34

Electromyography anorectal function and, 108:990 deglutitive vocal cord closure and, 108:1357 lower esophageal sphincter tone and, 108:441

Electron mlcrography HIV-associated necrotizing cholangltis caused by SeDtata intestinalis and, 108:247-cr pancreatitis and (rat), 108:1863

Elemental formulas childhood chronic intestinal pseudo-obstruction and, 108:1379 Crohn's disease and, 108:1056 role of, 108:1294-aga Encephalopathy, hepatic, quinolinic acid in, 108:818 Endocrine c e l l s , GI tract (db/db mice), 108:967

Endoplasmic reticulum cytochrome P4502B traffic and (rat), 108:1110 hepatocyte, chronic alcohol abuse and, 108:776 lumen, hepatic glucuronidation and (rat), 108:183

Endoscopic injection sclerotherapy, papilloma virus infection and, 10&550-cr

Endoscopic measurements, accuracy of, 108:941-ss

Endoscopic recurrence, of Crohn's disease, 108:310-tmig, 108:345

Endoscopic retrograde cholangiopancreatography cholangiocarcinoma in primary sclerosing cholangitis and, 108:865 HIV-associated necrotizing cholangitis and, 108:247-cr sphincter of Oddi dysfunction and, 108:242-cr

Endoscopic ultrasonography esophageal cancer and, 108:310-tmig, 108:337 pyogenic granuloma in Barrett's esophagus and, 108:1894-cr

Endoscopy achalasia-associated esophageal squamous cell carcinoma and, 108:545-cr advanced therapeutic, 108:1951-br antrai vascular ectasia and, 108:138 cost-effectiveness and, 108:1957-c dyspepsia and, 108:1324-ss glutaraldehyde colitis after, 108:1250-cr malignant colorectai polyps and, 108:1615-tmig, 108:1657 portal hypertensive gastropathy and, 108:138 rumination syndrome and, 108:957-tmig ulcerative colitis and, 108:1361

Endothelial cells monocyte-chemoattractant protein 1 and, 108:40 radiation-induced microvascular dysfunction and (rat), 108:1761 sinusoidal, VCAM-1 in chronic viral hepatitis and, 108:231 Endothelin receptors, on cecal circular smooth muscle cells (guinea pig), 108:51 Endothelin 1, cirrhosis and (rat), 108:1842

EndotheHum-derived relaxing factor, NO in ethanol-induced gastric mucosal injury and (rat), 108:58

Endotoxemia, alcohol-induced liver in-

1991

jury and (human, rat), 108:l-tmig, 108:218

Endotoxin alcohol-induced liver injury and (rat), 108:l-tmig, 108:218 bile canaIicular contraction and, 108:841 intestinal permeability and, 108:1576-srr nitric oxide production and (rat), 108:463 NO synthase in portal hypertension and (rat), 108:1487 Energy excretion, dietary stimulation of bifodobacteria and, 108:975 Enkephalins, opioid binding in cholestasis and (rat), 108:1479 Enolase, premalignant colon lesions and, 108:117

Enteral nutrition Crohn's disease and, 108:957-tmig, 108:1056 guidelines for use of, 108:1280-aga pediatric, 108:1603-br technical review of, 108:1282-aga

Enteric nervous system cholera toxin and (rat), 108:2-tmig, 108:34 histamine in duodenal bicarbonate secretion and (rabbit), 108:1676 ileal crypts and (mouse), 108:1345 Enteric neurotransmitters, neurons and, 108:554-srr Enterobacteriaceae, bacterial colonization of cholesterol gallstones and, 108:624-tmig

Enterochromaffinlike ceils circulating pancreastatin and (rat), 108:1445 dietary ammonium-induced hypergastrihernia and (rat), 108:l-tmig, 108:320 ileal crypts and (mouse), 108:1345 Enterocytes, villus, cystic fibrosis transmembrane conductance regulator and (rat, human), 108:1016 Enteroglucagon, GI tract endocrine ceils and (db/db mice), 108:967 Enteropathy, intestinal permeability and, 108:1574-srr

Enzyme-linked immunosorbent assay (ELISA) anti-hydroxyethyl free radical-modified albumin and, i08:l-tmig, 108:201 antineutrophil cytoplasmic antibodies and, 108:1159 IL-8 in HT-29 cells and, 108:653 IL-10 in IBD and, 108:1434 inflammatory bowel disease and, 108:21 microsomal autoantibodies in viral hepatitis and, 108:455

Enzyme-linked immunosorbent assay 2 (ELISA-2), changing

1992

SUBJECT INDEX

prevalence of HCV genotypes and, 108:581-rc EosinophH migration, agross epithelium, 108:409

Epidermal growth factor (EGF) acidic gastric juice and, 108:92 hepatocellular DNA synthesis and (rat), 108:477 intestinal growth and, i08:1330-c peptides related to, 108:564-srr Epigastric symptoms, gastric distension and, 108:330 Epithelial bridge formation, in Crohn's disease, 108:376

Epithelial cells esophageal, HCI and (rabbit), 108:662 ileal crypts and (mouse), 108:1345 intestinal, monocyte-chemoattractant protein 1 and, 108:40 Erosive esophagitis, omeprazole for, 108:613-ss E s c h e r i c h i a coli cirrhosis and (rat), 108:1835 colonization of cholesterol gallstones and, 108:861 Crohn's disease and, 108:1338-tmig, 108:1396, 108:!396 lipopolysaccharide, hepatic reperfusion injury and (rat), 108:463 E s c h e r i c h i a coli O157:H7 as emerging national health crisis, 108:1923-aga swimming-associated outbreak and, 108:1597-ss Esh avian sarcoma virus, premalignant colon lesions and, 108:117 Esophageal papilloma, papillomavirus in, 108:550-cr Esophagitis, erosive, omeprazole for, 108:613-ss

Esophagogastroduodenal manometry, rumination syndrome and, 108:1024

Esophagus cancer, photodynamic therapy for, 108:310-tmig, 108:337, 108:593-e epitheIium, HC1 and (rabbit), 108:662 gastroesophageal reflux in ambulant subjects and, 108:83 mucosal injury, duodenogastric reflux and, 108:1897-srr perforation, gastrografin for, 108:618-c peristalsis, nitric oxide synthase in (rat), 108:367 sclerotherapy and, 108:550-cr sensitization, noncardiac pain in, 108:311 squamous cell carcinoma achalasia-associated, 108:545-ct papillomavirus and, 108:1605-c Ethane, liver cell necrosis and, 108:257srr

GASTROENTEROLOGY Vol. 108, No. 6

Ethanol amino acid transport and, 108:899-srr anti-hydroxyethyl free radical-modified albumin and, 108:l-tmig, 108:201 antibiotics block liver injury by (rat), 108:l-tmig, 108:218 gastric metabolism of (rat), 108:737 gastric mucosal injury and (rat), 108:58 IGF-1 and (rat), 108:644 liver damage induced by, fatty acid ethyl esters and, 108:515 Ethyl arachidonate, HepG2 cells and, 108:515 Ethylene glycol polymers, intestinal permeability and, 108:1568-srr Ethyl oleate, HepG2 ceils and, 108:515

dietary stimulation of bifodobacteria and, 108:958-tmig, 108:975 induction of Na + and K + excretion in, 108:752 Feedback inhibition, central, pancreatic polypeptide and (rat), 108:1517 F e e d i n g , pancreastatin and (rat), 108:1445 Fenestration, cyst, in polycystic liver disease, 108:309-tmig, 108:487 Fermentable dietary fiber, epithelial cell proliferation and (mouse), 108:1745 Ferritin genetic hemochromatosis and, 108:ltmig, 108:208 hepatitis C virus and, 108:1104

Euglycemia

Fetus

glucose effects on colon motility and, I08:350 hyperglycemia-evoked gastric slow-wave dysrhythmias and, 108:727 rectoanal inhibitory reflex and, 108:1700 Euro-Collins solution, free radical production after cold storage and (rat), 108:1167

gastric mucosa in, 108:1650 liver development, pancreatic enzymes in, 108:1236 Fiber, dietary, epithelial cell proliferation and (mouse), 108:1745 Fiber-containing formulas, role of, 108:1296-aga F i b r i n , liver injury and (rat), 108:1124

European hepatoceHular carcinoma, p53 in, 108:1176 Excitatory motor neurons, transmit-

Fibrinogen

ters of, 108:557-srr

Exercise, gastroesophageai reflux in ambulant subjects and, 108:83

Eyes, Wilson's disease and, 108:885-cr F(ab' )2 fragments, SF-25 monoclonal antibody and (nude mice), 108:172

Familial adenomatous polyposis, sulindac and, 108:1083, 108:1311-e F a m i l y h i s t o r y , intestinal permeability in Crohn's disease and, 108:132 F a m i l y s u s c e p t i b i l i t y , hereditary nonpolyposis colorectal cancer and, 108:1337-tmig, 108:1405

Fasting intestinal permeability and, 108:1576-srr pancreastatin and (rat), 108:1445 rumination syndrome and, 108:1024

bovine, anti-hydroxyethyl free radicals in alcoholic cirrhosis and, 108:201 liver injury and (rat), 108:1124 Fibrogenesis, liver, growth factors and, 108:145 Fibrohyalinosis, antral vascular ectasia and, 108:138 Fibrosis, hepatic, 108:145, 108:1304 FHtration assay, bile canalicular contraction and, 108:841 Fine-needle aspiration, pancreatic cyst fluid analysis and, 108:958-tmig, 108:1230

First-degree relatives inflammatory bowel disease and, 108:428 intestinal permeability in Crohn's disease and, 108:2-tmig, 108:132 First-pass metabolism, ethanol (rat), 108:737

Fissures

Fat

Crohn's disease and, 108:1396

fecal consistency in diarrhea and, 108:1729 heartburn and, 108:125 F a t t y acid ethyl esters, hepatotoxicity of, 108:515, 108:60%e Fecal balance studies, amylase inhibition and (dog), 108:1221 F e c a l c o n s i s t e n c y , diarrhea and, 108:1729 F e c a l o o c y s t s , AIDS-related cryptosporidiosis and, 108:957-tmig, 108:1075 F e c a l v i r u s s h e d d i n g , hepatitis E virus infection and, 108:225

Listeria monocytogenes and, 108:1338-tmig,

Feces cryptosporidiosis with AIDS and, 108:627

108:1396

Flow cytometry achalasia-associated esophageal squamous cell carcinoma, 108:545-cr cytochrome P4502B traffic and (rat), 108:1110 intestinal permeability in Crohn's disease and, I08:132 K-ras-2 mutations in colon cancer and, 108:1040 opioid binding in cholestasis and (rat), 108:1479 pyruvate dehydrogenase and, 108:1802

June 1995

SUBJECT INDEX

VCAM-1 in chronic viral hepatitis and, 108:231 F l o w r a t e , intestinal permeability and, 108:983

Fusobacteria, dietary stimulation of bifo-

F l u o r e s c e i n i s o t h l o c y a n a t e albumin, radiation-induced microvascu-

G a d o l i n i u m c h l o r i d e , free radical production after cold storage and (rat), 108:1167 G a l a n i n , smooth muscle receptors and (dog, guinea pig), 108:3

lar dysfunction and (rat), 108:1761

Fluorescence microscopy bile canalicular contraction and, 108:841 pancreatic H+/HCO3 secretion and (pig), 108:850 F l u o r e s c e n t n e u r o n a l labeling, of NO synthase in brainstem (rat), 108:367 5-Fluororacil, intestinal permeability and, 108:1576-srr

6-Fluoro-ursodeoxychoHc acid anal o g u e , cholestatic liver disease and, I08:1204 F l u s h i n g , midget carcinoids and, 108:743

Follistatin hepatoma cells and, 108:834 liver regeneration and (rat), 108:1136

Food anti-inflammatory, 108:957-tmig, 108:1056 contamination, E col/O157:H7 and, 108:1926-aga gastroesophageal reflux in ambulant subjects and, 108:83 heartburn and, 108:2-tmig, 108:125 intolerance, intestinal permeability and, 108:1575-srr undigested, rumination syndrome and, 108:957-tmig, 108:1024

n-Forntyl-methionyl-leucylp h e n y l a l a n i n e (fMLP), eosinophil migration and, 108:409 F o r s k o l l n , IL-8 in HT-29 cells and, 108:653 F P L 5 5 7 1 2 , leukotriene C4 synthesis and (rat), 108:1793 F R - 1 3 9 3 1 7 , endothelin receptors and (guinea pig), 108:51

Free radicals alcoholic cirrhosis and 108:l-tmig, 108:201 hepatic production of after cold storage (rat), 108:1167, 108:1317-e hepatic reperfusion injury and (rat), 108:463 liver cell necrosis and, 108:257-srr Freston, J a m e s W., 108:1339-aga F r u c t o s e - l , 6 - b i p h o s p h a t e , ischemic liver protection and (rat), 108:1785 Fulguration, polycystic liver disease and, 108:309-trait F u n d e c t o m y , pancreastatin and (rat), 108:1445 F u r a - 2 / A M , ileal crypts and (mouse), 108:1345

dobacteria and, 108:958-tmig, 108:975

Gallbladder absorption, octreotide and (prarie dog), 108:1547 emptying, bile composition and, 108:1615-tmig, 108:1882 motility, cholecystectomy and, 108: 1332-c muscarinic receptors and, 108:1329-c

Gallstones cholesterol bacterial colonization of, 108:624-tmig, 108:860, 108:934-e nucleation of cholesterol crystals and, 108:1882 liver disease and, 108:1337-tmig, 108:1534 octreotide and (prairie dog), 108:1547 G a m m a camera i m a g i n g , cholangiocarcinoma and, 108:1908-rc G a s , intramural, pneumatosis cystoides intestinalis and, 108:1560-cr Gastrectomy, pancreastatin and (rat), 108:1445 Gastric acid, regulation of phi during exposure to (Necturus), 108:999

Gastric antral vascular ectasia (GAVE), portal hypertensive gastropathy and, 108:138 G a s t r i c d i s t e n s i o n , glucose effects on colon motility and, 108:309-tmig, i08:350 G a s t r i c d y s p l a s i a , stomach cancer and, 108:1955-c

Gastric e m p t y i n g E13~acerate breath test for, 108:957-tmig, 108:1048 mesalamine and, 108:1427 Gastric epithelium human spasmolytic polypeptide and, 108:108 inflammation induced by, 108:65 Gastric glands, zymogenic cell differentiation and (transgenic mice), 108:447

Gastric juice epidermal growth factor stability in, 108:92 Helicobacterpylori and (rat), 108:320 G a s t r i c l y m p h o m a , Helicobacter pylori and, 108:610-ss Gastric microcirculation, secondary biliary cirrhosis and (rat), 108:1183

1993

Gastric mucosa Helicobacte; fel/s and, 108:1386 lipase and, i08:1650 nitric oxide and (rat), 108:58 pepsin and, 108:1650 smoking and, 108:1329-c zymogenic cell differentiation and (transgenic mice), 108:447 Gastric t o n e , stomach sensitivity to distension and, 108:330 Gastrin antral vascular ectasia and, 108:i38 colon cancer and, 108:618-c, 108:1068, 108:1307-e ECL cells and (rat), 108:1445 GI tract endocrine ceils and (db/db mice), 108:967 Helicobacterpylori and (rat), 108:309-tmig, 108:320 G a s t r i n o m a , surgery and, 108:1600-ss G a s t r i t i s , vs gastropathy, 108:917-vodd Gastrocolonic r e s p o n s e , glucose effects on colon motility and, 108:309tmig, 108:350 G a s t r o d u o d e n a l m a n o m e t r y , rumination syndrome and, 108:1024

Gastroenterology clinical science and practice, 108:301-br principles and practice of, 108:1327-br

G a s t r o e s o p h a g e a l reflux d i s e a s e (GERD) cost-effectiveness analysis and, 108:303-c duodenogastric reflux and, 108:1897-srr Hz-receptor antagonists and, 108:1958-c relaxation training and, 108:619-c spatiotemporal reflux characteristics and, 108:1739

G a s t r o e s o p h a g e a l reflux mechan i s m s , in ambulant subjects, 108:83, 108:289-e

Gastrografin, esophageal perforation and, 108:618-c

Gastrointestinal tract atrial natriuretic peptide in cirrhosis and (rat), 108:1496 endocrit~e cells and (db/db mice), 108:967 immunology and, 108:1327-br physiology of, 108:948-br Gastrointestinal transit, amylase inhibition and (dog), 108:1221 Gastroparesis, diabetic, hyperglycemiaevoked gastric slow-wave dysrhythmias and, 108:727

Gastropathy Helicobacterpylori and (rat), 108:309-tmig, 108:320 NSAID (rat), 108:393 vs gastritis, 108:917-vodd Gastroscopy, conscious sedation and, 108:697, 108:932-e

1994

SUBJECT INDEX

GASTROENTEROLOGY Vol. 108, No. 6

Gastrostomy

Glucagon, gastric distension and, 108:330

Granulomatous inflammation

childhood chronic intestinal pseudo-obstruction and, 108:1379 placement of, 108:1280-aga use of, 108:1286-aga GAT mutations, colorectal aberrant crypt foci and, 108:434 Gaucher's disease, in children, 108:1266-srr G c e l l s , dietary ammonium-induced hypergastrinemia and (rat), 108:309-tmig, 108:320

G l u c o c o g t i c o i d s , ulcerative colitis and, 108:1889-cr Glucocorticosteroids, dexamethasone~-D-glucuronide and (rat), 108:1688

HIV-associated necrotizing cholangitis caused by Septata intestinalis and, 108:247-cr pancreatic, in Crohn's disease, 108: 1246-cr Granulomatous vasculitis, Crohn's disease and, 108:623-tmig, 108:911srr Grapefruit j u i c e , heartburn and, 108:2tmig Gr•sbeck-lmerslund disease, pathogenesis of, 108:1622 Growth, intestinal, epidermal growth factor and, 108:1330-c Growth factors, in liver disease, 108:145 GTT mutations, colorectal aberrant crypt loci and, 108:434 G u a n i n e , bacterial colonization of cholesterol gallstones and, 108:860 Guanosine triphosphate (GTP), hepatic glucuronidation and (rat), 108:183 Guanylyl cyclase, atrial natriuretic peptide in hepatic vasodilation and (rat), 108:803 Guar g u m ) epithelial cell proliferation and (mouse), 108:1745

Gel-filtration exclusion chromatography, Gr~isbeck-Imerslund disease and, 108:1622

Genes atrial natriuretic peptide, 108:1496 bacterial colonization of cholesterol gallstones and, 108:860 colon cancer and, 108:1337-tmig, 108:1405 Crohn's disease and, 108:1338-tmig, 108:1396 fibrinogen, 108:1124 growth factor, 108:145 histone, 108:1849 liver disease and, 108:145 monocyte-chemoattractant protein 1, 108:40 precore/core, of hepatitis B virus, 108:310tmig, 108:505 premalignant colon lesions and, 108:117, 108:291-e procollagen type I, 108:145 Genetic predisposition, chronic viral hepatitis and, 108:137 G e n e t i c t e s t i n g , hereditary nonpolyposis colorectal cancer and, 108:1337tmig, 108:1405 G e n i s t e i n , IL-8 in HT-29 cells and, 108:653 Genotnic variations, in hepatitis B core gene, 108:310-tmig, 108:505

Genotyping hepatitis C virus and, 108:581-rc, 108:958-tmig, 108:1088, 108: 1314-e primary sclerosing cholangitis and, 108:870, 108:937-e Germ-free m i c e , epithelial cell proliferation and (mouse), 108:1745 Ghosts, of dead ceils, 108:304-c Giant c e l l s , Crohn's disease and, 108:1396 Giardia lamblia, intestinal permeability and, 108:1574-srr Gilbert syndrome, carbonic anhydrase antibodies and, 108:1802 G i l l i a m ' s score, antrai vascular ectasia and, 108:138 G H a d i n , intestinal permeability and, 108:1573-srr

Glucose absorptive hyperemia and, 108:1599-ss amylase inhibition and (dog), 108:1221 colonic motility and, 108:309-tmig, 108:350 cryptosporidiosis and (piglet), 108:1030 duodenal HCO 3 secretion and, 108:102 follistatin and (rat), 108:1136 hyperglycemia-evoked gastric slow-wave dysrhythmias and, 108:623-tmig, 108:727 as intestinal brake, 108:1616-tmig, 108:1700 intestinal permeability and, 108:1569-srr Glucose intolerance formulas, role of, 108:1296-aga G l u c u r o u i d a t i o n , hepatic, 108:183, 108:1464 Glutamine brain edema and (rat), 108:1097 parenteral nutrition and, 108:1961-c

g-Glutamyltransferase colchicine and, 108:1470 ursodeoxycholic acid and, 108:1470 Glutaraldehyde colitis, after endoscopy, 108:1250-cr Gluten, intestinal permeability and, 108:1573-srr Glycerol, intestinal permeability and, 108:1569-srr G l y c l n e , 6-fluoro-ursodeoxycholic acid analogue and, 108:1204 Goblet4:ell hyperplasia, in Crohn's disease, 108:376 G o l g i apparatus cytochrome P4302B traffic and (rat), 108:1110 hepatic glucuronidation and (rat), 108:183 g p l 2 0 , HIV-associated diarrhea and, 108:1939-e Graft dysfunction, refrigerated donor livers and, 108:1337-tmig, 108:1510 Gram-negative bacteria, liver injury by alcohol blocked by antibiotics (rat), 108:l-tmig, 108:218 Gram-positive cocci, dietary stimulation of bifodobacteria and, 108:975

Granulocyte/macrophage colonystimulating factor (GM-CSF), eosinophil migration and, 108:409

Grauulomas colonic sarcoidosis and, 108:1556-cr Crohn's disease and, 108:1396 Listeria monocytogenesand, 108:1338-t mig, 108:1396 pyogenic, 108:1894-cr

Gut diseases of, 108:615-br stress and, 108:618-c Gut compliance, irritable bowel syndrome and, 108:636, 108:927-e Gut sensitivity, sympathetic nervous system and, 108:680 H +, gastric mucosal p h i regulation and (Necturus, 108:999 H+/HCO3 , pancreatic, secretin and (pig), 108:850 H2-blocker therapy, dyspepsia and, 108:1324-ss

H2 breath test dietary stimulation of bifodobacteria and, 108:975 pneumatosis cystoides intestinalis and, 108:1560-cr H2-receptor antagonists, gastroesophageal reflux disease and, 108:1958-c H 7 , IL-8 in HT-29 ceils and, 108:653 H 8 9 , IL-8 in HT-29 cells and, 108:653 H a l i d e e f f l u x , CF-IBE cells and, 108:584-rc Hand transcutaneous e l e c t r i c a l nerve s t i m u l a t i o n , gut distension and, 108:680 H B - E G F , gastrointestinal pathophysiology and, 108:574-sir HCO3 , hepatocellular DNA synthesis and (rat), 108:477

June 1995

HCO3 /C02, gastric mucosal p h i regulation and (Necturus, 108:999 Heartburn economic, 108:303-c postprandial, beverage acidity and, 108:2tmig, 108:125 sulindac and, 108:1083

Heat shock protein (Hsp) 60, in inflammatory bowel disease, 108:75 Helicobacterfelis, distribution of in stomach (mouse), 108:1386

Helicobacter pylori amoxicillin for, 108:1338-tmig, 108:1412 dietary ammonium-induced hypergastrinemia and (rat), 108:309-tmig, 108:320 gastric lymphoma and, 108:610-ss N%methyi histamine and, 108:958-tmig, 108:959 omeprazole for, 108:1338-tmig, 108:1412 Hematopoephyrin derivative, in photodynamic therapy for esophageal cancer, 108:310-tmig, 108:337 Hemihyperlx-ophy, multiple focal nodular hyperplasia of liver and, 108:1256-cr

Hemochromatosis duodenal ferritin synthesis and, 108:1tmig, 108:208 liver cell necrosis and, 108:264-srr Hemodialysis, changing prevalence of HCV genotypes and, 108:581-rc Hemodynamics, NO in ethanol-induced gastric mucosal injury and (rat), 108:58 Hemoglobin, antral vascular ectasia and, 108:138

Hemoglobin oxygen saturation, NO in ethanol-induced gastric mucosal injury and (rat), 108:58 Hemophilia, inflammatory bowel disease and, 108:1011, 108:1305-e

Hemorrhage liver transplantation for chronic hepatitis with common variable immunodeficiency and, 108:879-cr refractory TIPs and, 108:954-c

Hepatectomy brain edema and intracranial hypertension after (rat), 108:1097 follistatin and (rat), 108:1136 small heparocellular carcinoma and, 108:768 Hepatic arterial resistance, in cirrhosis, 108:1152 Hepatic failure formulas, role of, 108:1295-aga Hepatic preservation injury, proteolysis and, 108:1594-e

Hepatitis autoimmune

SUBJECT INDEX

ANCA and, 108:1159 carbonic anhydrase antibodies and, 108:1802 hepatitis C virus and, 108:1770, 108:1942-e interferon and, 108:1770, 108:1942-e chronic viral common variable immunodeficiency with, liver transplantation for, 108:879-cr immunologic features and HLA associations, 108:157 vascular adhesion molecule and, 108:231 membrane attack complex and, 108:309tmig, 108:495 Hepatitis A virus (HAV), intestinal permeability and, 108:1574-srr

Hepatitis B virus (HBV) genomic variations in precore/core gene of, 108:310-tmig, 108:505 HBeAg-positive chronic, HIV and, 108:1 tmig, 108:165 interferon c~ for, 108:310-tmig, 108:505 surface antigen, X region deletion mutants and, 108:1810 TNF-c~ and, 108:1337-tmig, 108:1453

Hepatitis C virus (HCV) autoimmune hepatitis and, 108:1770, 108:1942-e common variable immunodeficiency with, liver transplantation for, 108:879-cr core, cellular immune reactions and, 108:1957-c genotypes changing prevalence of, 108:581-rc in liver transplant recipients, 108:958tmig, 108:1088, 108:1314-e interferon for, 108:623-tmig, 108:789 interferon alfa for, 108:945-ss, 108:1104 mapping strategy for curing, 108:945-ss microsomal autoantibodies and, 108:455 quasispecies of, 108:623-tmig, 108:789 single-strand conformation polymorphism and, 108:789 therapy, hepatic iron concentration and, 108:1104

Hepatitis delta virus (HDV) microsomal autoautibodies and, 108:455 superinfection, natural history of, 108:796 viremia and, 108:623-tmig, 108:796 Hepatitis E v i r u s (HEY), viremia and, 108:l-tmig, 108:225 Hepatobiliary involvement, HIV-associated necrotiziug cholangitis caused by Septata i*2testinalis and, 108:247-cr Hepatoblastoma, fatty acid ethyl esters and, 108:515, 108:605-e

Hepatocellular carcinoma (HCC)

1995

changing prevalence of HCV genotypes and, 108:581-rc in cirrhosis, liver cell dysplasia as risk factor for, 108:624-tmig, 108:812 European, p53 in, 108:1176 hypoechoic nodular pattern and, 108:1778 simplified staging system for, 108:617-c small, risk for intrahepatic recurrence of, 108:768

Hepatocytes bile canalicular contraction and, 108:841 chronic alcohol abuse and, 108:776 cytochrome P4502B traffic and (rat), 108:1110 epidermal growth factor stability in gastric juice and, 108:92 fibrinogen and (rat), 108:1124 immunostaining for membrane attack complex of complement and, 108:309-tmig, 108:495 leukotriene C4 synthesis and (rat), 108:1793 multiple focal nodular hyperplasia of liver and, 108:1256-cr nitric oxide and, 108:841 pancreatic enzymes and, 108:1236 TNE-o: in HBV and, 108:1337-tmig, 108:1453 UGT and, 108:1464 Hepatology, principles and practice of, 108:1327-br

Hepatoma activin-follistatin system in, 108:834 liver cell dysplasia and, 108:624-tmig

Hepatomegaly polycystic liver disease and, 108:309-tmig multiple focal nodular hyperplasia of liver and, 108:1256-cr H E P E S b u f f e r , pancreatic H+/HCO3- secretion and (pig), 108:850

HepG2 cells activin-follistatin system in, 108:834 fatty acid ethyl esters and, 108:515 Herbimycin, IL-8 in HT-29 cells and, 108:653

Hereditary nonpolyposis c o l ~ rectal cancer (HNPCC), screening for, 108:1337-tmig, 108:1405, 108:1590-e Heterogeneity, in ulcerative colitis, 108:597-e Hexamethoniunt, colonic myoelectric complexes and (mouse), 108:1371

High-density lipoprotein (HDL) colchicine and, 108:1470 ursodeoxycholic acid and, 108:1470 High-lipid diet, epithelial cell proliferation and (mouse), 108:1745

High-pressure liquid chromatography (HPLC)

1996

SUBJECT INDEX

/5-carotene absorption and (ferret), 108:719 bile canalicular contraction and, 108:841 epidermal growth factor stability in gastric juice and, 108:92 intestinal permeability and, 108:1569-srr High-sodium diet, preascitic cirrhosis and, 108:1820 H i l a r intrahepatic bile ducts, pancreatic enzymes and, 108:1236

Histamine duodenal bicarbonate secretion and (rabbit), 108:1676 ileal vasodilator mechanisms and (guinea pig), 108:712 N'*-methyl histamine in Helicobacterpylori infection and, 108:958-tmig, 108:959 H i s t l d i n e d e c a r b o x y l a s e , N%methyl histamine in Helicobacterpylori infection and, 108:959

Histochemistry NO in primate colitis and (rhesus macaque), 108:705 NO synthase in esophageal peristalsis and (rat), 108:367 H i s t o l o g y , achalasia-associated esophageal squamous cell carcinoma, 108:545-cr Histones, soluble TNF-ce receptor and (rat), 108:t849

HLA-A2-restricted cytotoxic T-cell f u n c t i o n , genomic variations in precore/core gene of hepatitis B virus and, 108:505 H I A c l a s s I I , primary sclerosing cholangitis and, 108:870, 108:937-e HI.A-DQ, primary sclerosing cholangitis and, 108:870, 108:937-e

HI.A-DR chronic viral hepatitis and, 108:157 primary sclerosing cholangitis and, 108:870, 108:937-e HI.~_-DIS~, ulcerative colitis and, 108:423, 108:597-e HLE cells, activin-follistatin system in, 108:834

HMG CoA reductase liver disease and, 108:1337-tmig, 108:1534 taurocholate and (rat), 108:533 H o d g k i n ' s l y m p h o m a , remote, colonic sarcoidosis and, 108:1556-cr

Homeostasis gastrin (rat), 108:320 liver cell necrosis and, 108:254-srr Home parenteral nutrition, prognosis of, 108:1005, 108:1302-e Homologous restriction factor, immunostaining for membrane attack complex of complement and, 108:495

GASTROENTEROLOGY Vol. 108, No. 6

Homosexuality, male, IFN-ce therapy for chronic hepatitis B and, 108:l-tmig, 108:165

Horseradish peroxidase intestinal permeability and, 108:1574-srr pancreatitis and (rat), 108:1863 H P D - N R c e l l s , pancreatic cancer and (Syrian hamster), 108:1526

HT29 cells human spasmolytic polypeptide and, 108:108 interleukin 8 in, 108:653 Human immunodeficiency v i r u s

(HIV) IFN-ex therapy for chronic hepatitis B and, 108:l-tmig, 108:165 intestinal permeability and, 108:1575-srr necrotiziog cholaogitis, Septata intestinalis in, 108:247-cr octreotide and, 108:1616-tmig, 108:1753, 108:1939-e

Human papillomavirus esophageal squamous cell carcinoma and, 108:1605-c type 16, esophageal papilloma and, 108:550-cr

Human spasmol~tic polypeptlde ( h S P ) , gastric damage and, 108:108 HUVEC c e l l s , pancreatic cancer and (Syrian hamster), 108:1526

Hydrochloric acid (HCI) effect of o n V m and pHi in esophageal cells (rabbit), 108:662 epidermal growth factor stability in gastric juice and, 108:92

Hydrogen gas clearance nitric oxide and (cat), 108:1215 NO synthase in portal hypertension and (rat), 108:1487 Hydrolases, degradative, liver cell necrosis and, 108:259-srr Hydrophilic probes, colonic permeation of inulin and (rat), 108:12 Hydroxye~yl free radicals, alcoholic cirrhosis and, 108:l-tmig, 108:201 4-Hydroxynonenal, liver cell necrosis and, 108:257-srr 25-Hydroxyvitamin D3, osteopenia and, 108:417 Hyoscine, colonic myoelectric complexes and (mouse), 108:1371 Hyperactivity, diet and, 108:299-ss Hypercoagulabillty, Crohn's disease and, 108:911-srr Hyp~dynamic c i r c u l a t o r y s y n drome NO synthase in portal hypertension and (rat), 108:1487 TNF-oe and (rat), 108:761

Hyperemia absorptive, 108:1599-ss

secondary biliary cirrhosis and (rat), 108:1183

Hypergastrinemia colon cancer and (rat), 108:1068, 108:1307-e Hdicobacter pylori and (rat), 108:309-tmig, 108:320

HH~erglycemia acute antroduodenal dysautonomia and, 108:951-c colonic motility and, 108:309-tmig, 108:350 gastric slow-wave dysrhythmias and, 108:623-tmig, i08:727 rectal perception and, 108:1616-tmig, 108:1700

Hyperinsulinemia glucose effects on colon motility and, 108:310-tmig, 108:350 hyperglycemia-evoked gastric slow-wave dysrhythmias and, 108:727 Hyperkalemia, laxatives and, 108:752

Hyperosmolality cholera toxin and (rat), 108:34 intestinal permeability and, 108: 1569-srr lactulose/mannitol permeability ratios and (cat, human, rodent), 108:687 Hyperplasia, enterochromaffinlike cell, dietary ammonium-induced hypergastrinemia and (rat), 108:309-tmig, 108:320 Hyperpolarization, colonic myoelectric complexes and (mouse), 108:1371

Hypertension intracranial, after hepatectomy rat), 108:1097 portal intestinal permeability and, 108:1576srr nitric oxide synthase and (rat), 108:1487 secondary biliary cirrhosis and (rat), 108:1183 TNF-cz and (rat), 108:761 Hypervariable regions, hepatitis C virus and, 108:623-tmig, 108:789, 108:958-tmig Hypoechoic nodular pattern, hepatocellular carcinoma and, 108:1778 Hypogammaglobulinemia, intestinal permeability and, 108:1575-srr H y p o m o l i l i t ~ , antral, hyperglycemiaevoked gastric slow-wave dysrhythmias and, 108:727

Hypoxia liver cell necrosis and, 108:261-srr liver injury by alcohol blocked by antibiotics (rat), 108:218

June 1995

IrA anti-hydroxyethyl free radicals in alcoholic cirrhosis and, 108:l-tmig, 108:201 cryptosporidiosis with AIDS and, 108:624-tmig, 108:627

IgG anti-hydroxyethyl free radicals in alcoholic cirrhosis and, 108:l-tmig, 108:201 colchicine and, 108:1470 cryptosporidiosis with AIDS and, 108:627 ursodeoxycholic acid and, 108:1470 I g G 1 , antineutrophil cytoplasmic antibodies and, 108:1159

IgM colchicine and, 108:1470 cryptosporidiosis with AIDS and, 108:624-tmig, 108:627 hepatitis E virus infection and, 108:1tmig, 108:225 ursodeoxycholic acid and, 108:1470 viremia in hepatitis E infection and, 108:225 I l e a l c r y p t s , calcium dynamics in (mouse), 108:1345 I l e a l loop model, cholera toxin and (rat), 108:2-tmig, 108:34 l l e o a n a l a n a s t o m o s i s , osteopenia and, 108:417 l l e o a n a l p o u c h , mucosa of, 108:953-c

lleunt AIDS-related cryptosporidiosis and, 108:957-tmig amylase inhibition and (dog), 108:1221 Crohn's disease and, 108:310-tmig, 108:345 galanin receptors and (dog, guinea pig), 108:3 Gr~sbeck-Imerslund disease and, 108:1622 histamine vasodilatory mechanisms and (guinea pig), 108:712 Hsp60 expression and, 108:75 mesalamine microgranule delivery in, 108:i427 smooth muscle, platelet-activating factor receptors and (guinea pig), 108:1666 Immune cholangiopathies, carbonic anhydrase antibodies and, 108:1615tmig, 108:1802 Immune-mediated i n j u r y , liver cell necrosis and, 108:266-srr

Immune response anti-hydroxyethyl free radical-modified albumin and, 108:l-tmig, 108:201 chronic viral hepatitis and, 108:157 hepatitis C virus and, 108:1957< SF-25 monoclonal antibody and (nude mice), I08:172 Immunoblot analysis, kinesin inhibition and (rat), 108:824

SUBJECT INDEX

Immunocytochemistry, GI tract endocrine cells and (db/db mice), 108:967

Immunodeficiency intestinal permeability and, 108:1575-srr liver transplantation and, 108:879-cr Immunoelectron microscopy, cystic fibrosis transmembrane conductance regulator and (rat, human), 108:1016

Immunofluorescence cystic fibrosis transmembrane conductance regulator and (rat, human), 108:1016 microsomal autoantibodies in viral hepatitis and, 108:455 NO synthase in esophageal peristalsis and (rat), 108:367 perinuclar antineutrophil cytoplasmic antibodies and, 108:423 Immunoglobulins, primary sclerosing cholangitis and, 108:1199

Immunohistochemistry colorectal aberrant crypt foci and, 108:434 gastric carcinoids and, 108:296-ss genetic hemochromatosis and, 108:2-tmig oe6-integrin in pancreatic cancer and, 108:523 latent TGF-~l-binding protein and, 108:1873 monocyte-chemoattractant protein 1 in IBD and, 108:40 p53 protein in hepatocellular carcinoma and, 108:t176 TNF-c~ in HBV and, 108:1337-tmig, 108:1453 UGT and, 108:1464 VCAM-1 in chronic viral hepatitis and, 108:231 Immunohistology, fibrinogen/fibrin deposition and (rat), 108:1124 Immunolabeling, Crohn's disease and, 108:1396 Intntunologic diseases, concurrent, chronic viral hepatitis and, 108:157 Immunology, GI tract inflammation and, 108:1327-br

Immunoprecipitation c~6-integrin in pancreatic cancer and, 108:523 monocyre-chemoattractant protein 1 in IBD and, 108:40

Immunostainlng colorectal aberrant crypt loci and, 108:434 Crohn's disease and, 108:911-srr genetic hemochromatosis and, 108:208 membrane attack complex of complement and, 108:309-tmig, 108:495 p53 protein in hepatocellular carcinoma and, 108:1176 Impalement, HC1 in esophageal cells and (rabbit), 108:662 Incoagulable blood, inflammatory bowel disease and, 108:1305-e

1997

Index colonoscopy, colorectal adenoma and, 108:402

India, viremia in hepatitis E infection and, 108:l-tmig, 108:225

Indirect immunofluorescence, of antineutrophil antibodies in familial IBD, 108:428

Indomethacin gastric injury and (rat), 108:393 human spasmolytic polypeptide and, 108:108 hyperglycemia-evoked gastric slow-wave dysrhythmias and, 108:623-tmig, 108:727 intestinal permeability and, 108:1573-srr platelet-activating factor receptors and (guinea pig), 108:1666

Infection bleeding cirrhotic patients and, 108:1616tmig, 108:1828 intestinal permeability and, 108:1574-srr

Inflammation gastric epithelium and, 108:65 HIV-associated necrotizing cholangitis caused by Septata intestinalis and, 108:247-cr IGF-1 binding sites in colitis and (rat), 108:644 liver cell necrosis and, 108:266-srr liver disease and, 108:145 monocyte-chemoattractant protein 1 in IBD and, 108:40 neurogenic (rat), 108:295-ss platelet-activating factor receptors and (guinea pig), 108:1666 VCAM-1 in chronic viral hepatitis and, 108:231

Inflammatory bowel disease (IBD) antineutrophil cytoplasmic antibodies and, 108:428 bone density and, 108:1607-c cyclosporine and, 108:943-ss Hsp60 and, 108:75 inherited coagulation disorders and, 108:1011, 108:1305-e interleukin 10 and, 108:1338-tmig, 108:1434 intestinal permeability and, 108:1574-srr monocyre-chemoattractant protein 1 and, 108:40 mononuclear phagocyte response to IL-4 in, 108:21, 108:284-e nitric oxide and (rhesus macaque), 108:705 osteopenia and, 108:417 smoking and, 108:1616-tmig, 108:1683 Inflammatory c e l l s , fibrinogen/fibrin deposition and (rat), 108:1124 Inflammatory lesions, membrane attack complex of complement in hepatitis and, 108:495

1998

SUBJECT INDEX

I n f l u e n z a A v i r u s , Crohn's disease and, 108:1396

I n g e s t e d agents, human spasmolytic polypeptide and, 108:108

I n h i b i t o r y m o t o r n e u r o n s , transmitters of, 108:556-srr

Inositol- 1 , 4 , 5 - t r i p h o s p h a t e ( I n s P 3 ) , bile canalicular contration and, 108:841

In situ h y b r i d i z a t i o n fibrinogen/fibrin deposition and (rat), 108:1124 genetic hemochromatosis and, 108:2tmig, 108:208 IL-8 in HT-29 cells and, 108:653 liver disease and, 108:145 Insulin amylase inhibition and (dog), 108:1221 glucose effects on colon motility and, 108:310-tmig, 108:350 hyperglycemia-evoked gastric slow-wave dysrhythmias and, 108:727 IGF-1 and (rat), 108:644 rectoanal inhibitory reflex and, 108:1700

I n s u l i n l i k e g r o w t h factor 1 (IGF1), binding sites, in colitis (rat), 108:644

I n s u r a n c e c a r r i e r s , use of medical practice guidelines by, 108:925-paps ot6-1ntegrin , in pancreatic cancer, 108:523 I n t e g r i n s , eosinophil migration and, 108:409 Intention-to-treat p r i n c i p l e , Crohn's disease and, 108:1056

Intercellular a d h e s i o n m o l e c u l e 1 (ICAM-I) eosinophil migration and, 108:409

Helicobacterpylori infection and, 108:65 radiation-induced microvascular dysfunction and (rat), 108:1761

I n t e r f e r o n (IFN) autoimmune hepatitis and, 108:1770, 108:1942-e hepatitis C virus and, 108:623-tmig, 108:789

I n t e r f e r o n alfa (IFN-~) 2',5'-adenylate syntherase and (rat), 108:1192 bile acids and (rat), 108:1192 changing prevalence of HCV genotypes and, 108:581-rc cholestasis and (rat), 108:1192 genomic variations in precore/core gene of hepatitis B virus and, 108:310-tmig, 108:505 HBeAg-positive chronic hepatitis B and, 108: 1-tmig, 108:165 Helicobacter pylori infection and, 108:65 hepatic iron concentration and, 108:1104 hepatitis C virus and, 108:945-ss natural killer cells and (rat), 108:1192

GASTROENTEROLOGY Vol. 108, No. 6

TNF-c~ in HBV and, 108:1337-tmig, 108:1453 I n t e r f e r o n beta (IFN-~), Helicobacter pylori infection and, 108:65 I n t e r f e r o n g a m m a (IFN-T) , Helicobacter pylori infection and, 108:65

I n t e r l e u k i n 1 r e c e p t o r a g o n i s t (II~ lra) inflammatory bowel disease and, 108:21 interleukin 10 in IBD and, 108:1434

I n t e r l e u k i n 16 (II~l~) HT-29 cells and, 108:653 inflammatory bowel disease and, 108:21, 108:284-e interleukin 6 and (rat), 108:1720 interleukin 10 in IBD and, 108:1338tmig, 108:1434 monocyte-chemoattractant protein 1 and, 108:40

Interleukin 2 (Ib2) Crohn's disease and, 108:1338-tmig, 108:1396 Hdicobacter pylori infection and, 108:65 polymorphonuclear leukocyte margination and (rat), 108:393 I n t e r l e u k i n 4 (IL-4), mononuclear phagocytes in inflammatory bowel disease and, 108:21, 108:284-e

I n t e r l e u k i n 6 (II~6) Helicobacter pylori infection and, 108:65 interleukin 1/3 and (rat), 108:1720 I n t e r l e n k i n 8 (II~8) Helicobacterpylori infection and, 108:65 HT-29 cells and, 108:653 I n t e r l e n l d n 10 (IL-IO) Crohn's disease and, I08:1338-tmig, 108:1396 inflammatory bowel disease and, 108:1338-tmig, 108:1434 pancreatitis and, 108:1917-rc I n t e r v e n t i o n a l r a d i o l o g y , at crossroads, 108:951-c Intervlllus space, jejunal, flow rate and, 108:983 I n t e s t i n a l b r a k e , glucose as, 108:1616tmig, 108:1700 I n t e s t i n a l f a i l u r e , nonmalignant chronic, home parenteral nutrition and, 108:1005, 108:1302-e I n t e s t i n a l g r o w t h , epidermal growth factor and, 108:1330-c I n t e s t i n a l i n j u r y , AIDS-related cryptosporidiosis and, 108:957-tmig, 108:1075 I n t e s t i n a l m o t i l i t y , in childhood chronic intestinal pseudo-obstruction, 108:1379 Intestinal permeability Crohn's disease and, 108:2-tmig, 108:132 overview of, 108:1566-srr I n t e s t i n a l s t e r i l i z a t i o n , endotoxin

production in alcohol-induced liver injury and (rat), 108:218 Intracerebral bleed, polycystic liver disease and, 108:487 Intracranial h y p e r t e n s i o n , after hepatectomy rat), 108:1097 Intragastric f e e d i n g , liver injury by alcohol blocked by antibiotics (rat), 108:218 Intragastric neutralization, epider~ real growth factor stability in gastric juice and, 108:92

Intrahepatic biliary epithelial c e l l s , complementation of cystic fibrosis defect in, 108:584-rc I n t r a l u m i n a l t r a n s d u c e r s , gastroesophageal reflux in ambulant subjects and, 108:83

Intrinsic factor-cobalamin receptor, Gr~isbeck-Imerslund disease and, 108:1622 Inulin colonic permeation of (rat), 108:12 dietary stimulation of bifodobacteria and, 108:958-tmig, 108:975 intestinal permeability and, 108:1569-srr

Ion exchange chromatography, gastric ethanol metabolism and (rat), 108:737 I o n i z i n g r a d i a t i o n , microvascular dysfunction and (rat), 108:1761 I o n transport, gastric mucosal pHi regulation and (Necturus, 108:999

Iron genetic hemochromatosis and, 108:208 hepatic concentration, hepatitis C therapy and, 108:1104 liver cell necrosis and, 108:264-srr metabolism in health and disease, 108:1328-br I r o n r e g u l a t o r y factor, genetic hemochromatosis and, 108:2-tmig, 108:208

Irritable b o w e l s y n d r o m e (IBS), mechanical hypersensitivity in, 108:636, 108:927-e

Ischemia cold, refrigerated donor livers and, 108:1337-tmig, 108:1510 fructose-l,6-biphosphate and (rat), 108:1785 hepatic reperfusion injury and (rat), 108:463 ISO2, NO in ethanol-induced gastric mucosal injury and (rat), 108:58 I s o e l e c t r o f o c u s i n g , Gr~isbeck-Imerslund disease and, 108:1622 I s o l e u c i n e , refrigerated donor livers and, 108:1510 I s o p r o t e r e n o l , ileal crypts and (mouse), 108:1345

June 1995

Israel, smoking in IBD and, 108:1616tmig, 108:1683

SUBJECT INDEX

free radical production after cold storage and (rat), 108:1167, I08:1317< TNF-oe and, 108:1337-tmig, 108:1453

Jaundice, viremia in hepatitis E infection and, 108:l-tmig

Jejunal feeding, in childhood chronic intestinai pseudo-obstruction, 108:1379

Jejunostomy tubes childhood chronic intestinal pseudo-obstruction and, 108:1379 use of, 108:1289-aga

Jejunum cholera toxin and (rat), 108:2-tmig, 108:34 flow rate and, 108:983 mesalamine microgranule delivery in, 108:1427 smooth muscle, myenteric denervation and (rat), 108:1629

Jewish ethnicity smoking in IBD and, 108:1616-tmig, 108:1683 ulcerative colitis and, 108:423 g +

HCI in esophageal cells and (rabbit), 108:662 induction of fecal excretion of, 108:752 gato I I I cells, Helicobacterpylori infection and, 108:65

Kidney microsomal proteins CYP2D6 antigenic sites and, 108:470 viral hepatitis and, 108:455

Kidneys endothelin 1 and (rat), 108:1842 transplantation of, changing prevalence of HCV genotypes and, 108:581-rc Wilson's disease and, 108:885-cr Kinases, premalignant colon lesions and, 108:117, 108:291-e K i n e s i n , hepatic, bile acid inhibition of (rat), 108:824

Klippel-Tr~naunay-Weber syndrome, multiple focal nodular hyperplasia of liver and, 108:1256-cr

Knockouts Crohn's disease and, 108:1338-tmig, 108:1396 interleukin 10 in IBD and, 108:1434 K - r a s oncogene colitis-associated neoplasias and, 108:383 colorectal aberrant crypt foci and, 108:434, 108:600-e colorectal adenoma and, 108:1040 grebs-Henseleit buffer, free radical production after cold storage and (rat), 108:1167

Kupffer ceils alcohol-induced liver injury and (rat), 108:l-tmig, 108:218

Lactase, cystic fibrosistransmembrane conductance regulator and (rat, human), 108:1016 ~ - L a c t o g l o b u l i n , intestinal permeabiiity and, 108:1575-srr Lactose-contalning diets, role of, 108:1294-aga Lactose-free diets, role of, i08:1294aga

Lactulose AIDS-related cryptosporidiosis and, 108:1075 intestinal permeability and, 108:132, 108:687, 108:1568-srr

Lamina proprla Crohn's disease and, 108:1396 cryptosporidiosis with AIDS and, 108:627 Lk'teria monocytogenesand, 108:1338-tmig, 108:1396 monocyte-chemoattractant protein 1 and, 108:40

Lamina propria inflammatory ceils, cryptosporidiosis and (piglet), 108:1030

Lamina propria mononuclear cells (LPMNCs) inflammatory bowel disease and, 108:21, 108:284-e interleukin 10 in IBD and, I08:1434 Lanreotide, cholangiocarcinoma and, 108:1908-rc Laparoscopic biopsy, multiple focal nodular hyperplasia of liver and, 108:1256-cr Laparoscopy, diagnostic, color atlas of, 108: I604-br Large i n t e s t i n e dexamethasone-fl-D-glucuronide and (rat), 108:1688 dietary stimulation of bifodobacteria and, 108:975 endocrine cells and (db/db mice), 108:967 Laryngeal closure, tracheostomy and, 108:1357 L a r y n x , papilloma-carcinoma sequence in, 108:550-cr Laser Doppler flowmetry, secondary biliary cirrhosis and (rat), 108:1183 Laser irradiation, in photodynamic therapy for esophageal cancer, 108:3 lO-tmig, 108:337

Latent TGF-~ 1-binding protein (LTBP), pancreatitis and, 108:1873 L a x a t i v e s , in fecal Na + and K + excretion, 108:752

1999

L e u c l n e , refrigerated donor iivers and, 108:1510

Leukocyte-endothelial cell adhesion, radiation-induced microvascular dysfunction and (rat), 108:1761

Leukocyte margination, in indomethacin-induced gastric injury (rat), 108:393 L e u k o t r t e n e C4, bile transport and (rat), 108:1793 Leukotrienes, pepsinogen secretion and (guinea pig), 108:1709 Lewis lung carcinoma, angiostatin and, 108:1946-ss L i d o c a i n e , conscious sedation for gastroscopy and, 108:697, 108:932-e L i f e t i m e r i s k , hereditary nonpolyposis colorectal cancer and, 108:1405 Ligation assay, of APC mutations, 108:383 Line probe genotyping assay, for hepatitis C virus, 108:1088

Lipase fetal gastric mucosa and, 108:1650 IL-10 in pancreatitis and, 108:1917-rc liver development and, 108:1236 pancreatitis and (rat), 108:1855 Lipid bilayers, hepatocyte, chronic alcohol abuse and, 108:776 Lipid hydroperoxy radicals, liver cell necrosis and, 108:257-srr Lipid peroxidation, liver cell necrosis and, 108:257-srr

Lipids fermentable, epithelial ceil proliferation and (mouse), 108:1745 octreotide and (prairie dog), 108:1547

Lipopolysaccharide (LIPS) gastric epithelium and, 108:65 hepatic reperfusion injury and (rat), 108:463 polymorphonuclear leukocyte margination and (rat), 108:393 5-Lipoxygenase, leukotriene C4 synthesis and (rat), 108:1793 L i q u i d bolus, deglutitive vocal cord closure and, 108:1357 L i q u i d diet therapy, for Crohn's disease, 108:957-tmig, 108:1056 L i q u i d p h a s e , [13]acetate breath test for gastric emptying and, 108:957-tmig, 108:1048 L i q u i d sensor microelectrodes, gastric mucosal pHi regulation and (Necturus, 108:999 L i q u i d test meals, [13]acetate breath test for gastric emptying and, 108:957tmig, 108:1048 L i s t e r i a m o n o c y t o g e n e s , Crohn's disease and, 108:1337-tmig, 108:1396, 108:1589-e

2000

SUBJECT INDEX

Liver activin-follistatin system and, 108:834 amino acid transport and, 108:888-srr atrial natriuretic peptide and (rat), 108:803, 108:1496 biology and pathobiology, 108:1603-br biopsy, primary sclerosing cholangitis and, 108:1199 brown pigment gallstones and, 108:1337tmig, 108:1534 cancer changing prevalence of HCV genotypes and, 108:581-rc fatty acid ethyl esters and, 108:515 hypoechoic nocular pattern and, 108:1778 liver cell dysplasia as risk factor for in cirrhosis, 108:624-tmig, 108:812 p53 in, 108:1176 risk for intrahepatic recurrence of, 108:768 simplified staging system for, 108:617C

carbon tetrachoride injury, soluble TNFoe receptor and (rat), 108:1616-tmig, 108:1849 childhood metabolic disease of, 108:1263srr chronic alcohol abuse and, 108:776 cirrhosis anti-hydroxyethyl free radical-modified albumin and, 108:l-tmig, 108:201 antral vascular ectasia and, 108:138 atrial natriuretic peptide and (rat), 108:1496 bacteria and, 108:1616-tmig, 108:1828 bacterial translocation and (rat), 108:1835 changing prevalence of HCV genotypes and, 108:581-rc endothelin 1 and (rat), 108:1842 gastric microcirculation and (rat), 108:1183 genomic variations in precore/core gene of hepatitis B virus and, 108:505 HCV genotyping and, 108:1088 hepatic arterial resistance in, 108:1t52 hepatocellular carcinoma and, 108:624tmig, 108:812 intestinal permeability and, 108:1576srr NO synthase in portal hypertension and (rat), 108:1487 oxygen supplementation and (rat), 108:1504 portal hypertensive gastropathy and, 108:138 small heparocellular carcinoma and, 108:768 sodium handling and, 108:1820 theophylline and (rat), 108:1504

GASTROENTEROLOGY Vol. 108, No. 6

cysteinyl leukotrienes and (rat), 108:1793 development, pancreatic enzymes in, 108:1236 disease 6-fluoro-ursodeoxycholic acid analogue and, 108:1204 gallstones and, 108:1337-tmig, 108:1334 growth factors in, 108:145 donor, refrigeration of, 108:1337-tmig, 108:1510 encephalopathy, quinolinic acid in, 108:818 ethanol-induced damage and, 108:515 fatty acid ethyl esters and, 108:515 fibrinogen/fibrin deposition and (rat), 108:1124 free radical production after cold storage and (rat), 108:1167, 108:1317-e HIV-associated necrotizing cholangitis caused by Septata intestinalis and, 108:247-cr immunostaining for membrane attack complex of complement and, 108:309-tmig, 108:495 injury, antibiotics and (rat), 108:l-tmig, 108:218 iron concentration, hepatitis C therapy and, 108:1104 ischemia-reperfusion, fmctose-l,6-biphosphate and (rat), 108:1785 metastases colon cancer and (nude mice), 108:172 Zollinger-Ellison syndrome and, 108:1637 microsomal UDP-glucuronic acid uptake and (rat), 108:183 mitochondrial DNA deletion, in alcoholics, 108:193 muttiple focal nodular hyperplasia of, 108:1256-cr Na+/H + exchange and, 108:305-c necrotic, brain swelling and (rat), 108:1097 proteolysis and, 108:1594-e regeneration, follistatin and (rat), 108:1136 reperfusion injury, nitric oxide in (rat), 108:463, 108:603-e resection, in polycystic liver disease, 108:309-tmig, 108:487 signal transduction, nitric oxide and, 108:841 sphincter of Oddi dysfunction caused by ampullary neoplasm and, 108:242-cr surgery of, 108:1951-br TNF-ol and, 108:572-srr, 108:1337-tmig, 108:1453 transplantation alcoholism and, 108:615-br

cholangiocarcinoma in primary sclerosing cholangitis and, 108:865 for chronic hepatitis with common variable immunodeficiency, 108:879-cr HCV genotyping and, 108:958-tmig, 108:1088, 108:1314-e intestinal permeability and, 108:1576srr refrigerated donor livers and, 108:1337tmig, 108:1510 uridine 5'-diphosphate-glucuronosyltransferase and, 108:1464 VCAM-1 in chronic viral hepatitis and, 108:231 Wilson's disease and, 108:885-cr Liver cell dysplasia, as risk factor for hepatocellular carcinoma in cirrhosis, 108:624-tmig, 108:812 Liver cell necrosis, cellular mechanisms and clinical impliciations, 108:252srr

Liver m i c r o s o m a l proteins CYP2D6 antigenic sites and, 108:470 viral hepatitis and, t08:455 LK1 and LK2 m o n o c l o n a l antibodies, Hsp60 expression and, 108:75 LKM autoantEbodies CYP2D6 antigenic sites and, 108:470 viral hepatitis and, 108:455 L-NAME hepatic reperfusion injury and (rat), 108:463 pancreatitis and (rat), 108:1855 L-NMIlltA histamine ileal vasodilatory mechanisms and (guinea pig), 108:712 nitric oxide and (cat), 108:1215 L-NNA, NO in ethanol-induced gastric mucosal injury and (rat), 108:58 Long-distance runners, intestinal permeability and, 108:1576-srr Long-tel'In SUl'Wival, after photodynamic therapy for esophageal cancer, 108:310-tmig, 108:337, 108:593-e Loose stools, fecal consistency and, 108:1729 Loperanlide, HIV-associated diarrhea and, 108:1940-e Low-density lipoprotein (LDL), HepG2 cells and, 108:515 Lower b o d y negative pressure (LBNP), gut distension and, 108:680 Lower e s o p h a g e a l sphincter (LES) gastroesophageal reflux in ambulant subjects and, 108:83, 108:289-e pharyngeal water stimulation and, 108:441 spatiotemporal reflux characteristics and, 108:1739

June 1995

Low-Hpid diet, epithelial cell proliferation and (mouse), 108:1745 L o w - s o d i u m diet, preascitic cirrhosis and, 108:1820

Lumen endoplasmic reticulum, hepatic glucuronidation and (rat), 108:183 gastric, Helicobacterpylori and (rat), 108:320 intestinal, mesalamine microgranules in, 108:1338-tmig, 108:1427 Luminal acid, regulation of ph; during exposure to (Necturus), 108:999

Lung cancer, angiostatin and, 108:1946-ss endothelin 1 and (rat), 108:1842 papilloma-carcinoma sequence in, 108:550-cr L y m p h a d e n o p a t h y , colonic sarcoidosis and, 108:1556-cr

Lymph nodes Crohn's disease and, 108:1338-tmig, 108:1396 mesenteric, bacterial translocation and (rat), 108:1835 metastases malignant colorectal polyps and, 108:i657 Zollinger-Ellison syndrome and, 108:1637

Lymphocytes opioid binding in cholestasis and (rat), 108:1479 VCAM-1 in chronic viral hepatitis and, 108:231

Lymphoma gastric, 108:610-ss pyogenic granuloma in Barrett's esophagus and, 108:1894-cr Lysine, refrigerated donor livers and, 108:1510 Lysis, cell, immunostaining for membrane attack complex of complement and, 108:309-tmig, 108:495 2*Lyso-~-acetyl-T-O-hexadecyl , eosinophii migration and, 108:409 Lysolecithin, duodenogastric reflux and, 108:1903-srr

M I 5 a n t a g o n i s t , galanin effect on smooth muscle cells and, 108:3

M35 a n t a g o n i s t , galanin effect on smooth muscle ceils and, 108:3

M a c r o p h a g e - d e p l e t l n g agents, SF25 monoclonai antibody and (nude mice), 108:172 M a c r o p h a g e m a n n o s e receptor, inflammatory bowel disease and, 108:21

Macrophages Crohn's disease and, 108:1396

SUBJECT INDEX

infammatory bowel disease and, 108:21, 108:284-e Listeria monocytogenesand, 108:1338-tmig, 108:1396 monocyte-chemoattractant protein 1 in IBD and, 108:40 Macrovesicular s t e a t o s i s , impaired mitochondrial function and, 108:193

Magnetic r e s o n a n c e cholangiography, choledocholithiasis and, 108:1948-ss

Magnetic r e s o n a n c e i m a g i n g ( M R I ) , multiple focal nodular hyperplasia of liver and, 108:I256-cr

Magnetic r e s o n a n c e s p e c t r o s c o p y (MRS), in chronic alcohol abusers, 108:776

Malabsorption AIDS-related cryptosporidiosis and, 108:1075 cobalamin, Gr~isbeck-Imerslund disease and, 108:1622 tropical, intestinal permeability and, 108:1575-srr M a l a r i a , intestinal permeability and, 108:1574-srr M a l l o r y b o d i e s , anti-hydroxyethyl free radicals in alcoholic cirrhosis and, 108:l-tmig, 108:201 M a l o n d i a l d e h y d e , liver cell necrosis and, 108:257-srr M a m m a l s , Hsp60 expression and, 108:75

M a n u a l e v a c u a t i o n , after posterior rhizotomy, 108:990

Mass s p e c t r o s c o p y epidermal growth factor stability in gastric juice and, i08:92 quinolinic acid and, 108:818 Mast c e l l s , histamine in duodenal bicarbonate secretion and (rabbit), 108:1676 Matrix-produc/ng c e l l s , fibrinogen/ fibrin deposition and (rat), 108:1124

Meals amylase inhibition and (dog), 108:1221 distension and, 108:330 labeled, mesalamine ingestion with, 108:1338-tmig, 108:1427 rumination syndrome and, 108:1024 standardized, gastroesophageal reflux in ambulant subjects and, 108:83 Measles v i r u s , Crohn's disease and, 108:623-tmig, 108:911-srr, 108:1396 Mechanical stress, Crohn's disease and, 108:911-srr

Mechanoreceptor-mediatedg a s t r o c o l o n i c r e s p o n s e s , glucose effects on colon motility and, 108:350

M e c h a n o s e n s i t / v e i n t e s t i n a l afferents, in irritable bowel syndrome, 108:636, 108:927-e

Medical practice g u i d e l i n e s , use of

M a n a g e d care o r g a n i z a t i o n s , use of medical practice guidelines by, 108:925-paps

Mandibular l y m p h a d e n o p a t h y , coIonic sarcoidosis and, 108:1556-cr

by managed care organizations and insurance carriers, 108:925-paps

Medium-chain triglycegide formulas, role of, 108:1296-aga Mellblose, intestinal permeability and,

Mannitol AIDS-related cryptosporidiosis and, 108:1075 cholera toxin and (rat), 108:34 intestinal permeability and, 108:132, 108:687, 108:1569-srr M a n n o s e , inflammatory bowel disease and, 108:21

Manometry anorectal function and, 108:990 childhood chronic intestinal pseudo-obstruction and, 108:1379 esophageal sensitization in noncardiac pain and, 108:31i hyperglycemia-evoked gastric slow-wave dysrhythmias and, 108:727 lower esophageal sphincter tone and, 108:441 rumination syndrome and, 108:957-tmig, 108:t024 sphincter of Oddi dysfunction and, 108:242-cr tongue force modulation and, 108:1418

2001

108:1569-srr

M e m b r a n e attack c o m p l e x , in acute hepatitis, 108:309-tmig, 108:495

M e m b r a n e cofactor p r o t e i n , immunostaining for membrane attack complex of complement and, 108:495 M e m b r a n e potential, colonic myoelectric complexes and (mouse), I08:1371 M e m b r a n e t r a n s l o c a t i o n , in liver microsomal vesicles (rat), 108:183 M e m b r a n e t r a n s p o r t e r s , amino acid transport and, 108:888-srr M e m b r a n e voltage, HCI in esophageal cells and (rabbit), 108:662

Men aspirin vs colonoscopy in reduction of colon cancer risk in, 108:612-ss colonic sarcoidosis in, 108:1556-cr HIV-associated necrotizing cholangitis in, 108:247-cr IFN-a for chronic hepatitis B in HIV infection, 108:l-tmig, 108:165

2002

SUBJECT INDEX

pneumatosis cystoides intestinalis in, 108:i560-cr pyogenic granuloma in Barrett's esophagus and, 108:1894-cr sphincter of Oddi dysfunction in, 108:242 ulcerative colitis in, 108:1889-cr 3-Mercaptopropionate, in distal coionic apical membrane vesicles (rat), 108:673 6-Mercaptopurine, Crohn's disease and, 108:1936-e Mercyism, rumination syndrome and, 108:957-tmig Mesalamine Crohn's disease and, 108:310-tmig, 108:345, 108:1338-tmig, I08:1427, 108:1935-e oral microgranules, intestinal delivery of, 108:1427 ulcerative colitis and, 108:1889-cr Mesenchymal c e l l s , growth factors and, 108:145 Mesenteric blood supply, Crohn's disease and, 108:911-srr

Mesenteric lymph duct cannulation, /3-carotene absorption and (ferret), 108:719

Mesenteric lymph nodes bacterial translocation and (rat), 108:1835 Crohn's disease and, 108:1396 Mesenteric venules, radiation-induced microvascular dysfunction and (rat), 108:1761

Messenger RNA (mRNA) actin, 108:320 activin A, 108:834 atrial natriuretic peptide, 108:1496 cholesterol 7ex-hydroxylase, 108:533, 108:1534 cytokine, 108:1338-tmig, 108:1434 endothelin 1, 108:1842 ferritin, 108:l-tmig, 108:208 fibrinogen, 108:1124 gastrin, 108:320 growth factor, 108:145 HMG CoA reductase, 108:1534 interleukin 6, 108:1720 interleukin 8, 108:65, 108:653 MCP-1, 108:40 Na+/H + exchange and, 108:305-c procollagen type I, 108:145 SSTR2, 108:1908 TGF-ce, 108:1526 TGF-~I, 108:145, 108:1873 TNF-c~, 108:i917-rc vascular endothelial growth factor, 108:1526 Meta-analysis, of enteral feeding in Crohn's disease, 108:957-trnig, 108:1056

GASTROENTEROLOGY Vol. 108, No. 6

Metabolic liver disease, childhood, 108:1263-srr

Metabolism bone, 108:417 calcium, after myenteric denervation (rat), 108:1629 copper, 108:885-cr ethanol (rat), 108:737 iron, 108:1328-br

Metal-catalyzed decomposition, liver cell necrosis and, 108:257-srr M e t a l storage diseases, liver cell necrosis and, 108:264-srr

Metastases angiostatin and, 108:1946-sa colon cancer, inhibition of (nude mice), 108:172 6~6-integrin in pancreatic cancer and, 108:523 lymph node, malignant colorectal polyps and, 108:1657 small heparocellular carcinoma and, 108:768 Zollinger-Ellison syndrome and, 108:1637

Methionine HepG2 cells and, 108:515 refrigerated donor livers and, 108:1510

Methotrexate Crohn's disease and, 108:1936-e intestinal permeability and, 108:1576-srr

6-Methoxy-N-(-3-sulfopropyl)quinoHnium, CF-IBE cells and, 108:584-rc

Methylazoxymethanol, hypergastrinemia in colon cancer and (rat), 108:1068

N%Methyl histamine, Helicobacterpylori infection and, 108:958-tmig, 108:959 M e t r o n i d a z o l e , Crohn's disease and, 108:1615-tmig, 108:1617, 108:1935-e M e x i c o , hepatitis E virus infection and, 108:1-tmig M g ~+, hepatic glucuronidation and (rat), 108:183

Microelectrodes intracellular, HCI in esophageal cells and (rabbit), 108:662 liquid sensor, gastric mucosal pHi regulation and (Necturus, 108:999 Microflora, feeding, 108:958-tmig, 108:975 Microgranules, mesalamine, 108:1338tmig, 108:1427 Microinjection, pancreatic polypeptide and (rat), 108:1517

Microlymphotoxicity technique, chronic viral hepatitis and, 108:157

Micrometastases, hepatic, inhibition of in colon cancer (nude mice), 108:172

Microorganisms Crohn's disease and, 108:1338-tmig, 108:1396 Hsp60 expression and, 108:75

Microplate enzyme-linked immunosorbent assay, anti-hydroxyethyl free radical-modified albumin and, 108:l-tmig, 108:201 Microscopic image analysis, bile canalicular contraction and, 108:841

Microsomal antibodies CYP2D6 antigenic sites and, 108:470 viral hepatitis and, 108:455 Microsomal proteins, anti-hydroxyethyl free radical-modified albumin and, 108:l-tmig, 108:201 Microsomal vesicles, hepatic, UDPglucuronic acid and (rat), 108:183 Microspheres, radiolabeled, NO synthase in portal hypertension and (rat), 108:1487 Microsporidia, HIV-associated necrotizing cholangitis and, 108:247-cr

Microtubule affinity binding, kinesin inhibition and (rat), 108:824

Microtubnles, cytochrome P4502B traffic and (rat), 108:1110

Microvascular dysfunction, leukocyte-endothelial cell adhesion and (rat), 108:1761 Microvascular endothelium, mesenteric, Crohn's disease and, 108:911srr Microvaseular hyperemia, absorptive, 108:1599-ss Microvesicular steatosis, impaired mitochondrial function and, 108:193 Midazolam, conscious sedation for gastroscopy and, 108:697, 108:932-e Midget carcinoid flush, biogenic amines and, 108:743

Migrating action potential complexes ( M A P C s ) , cholera toxin secretion and, 108:287-e

Migrating motor complex (MMC), childhood chronic intestinal pseudoobstruction and, 108:1379 Migration, eosinophil, 108:409 M i l k , heartburn and, 108:125 Misoprostol, secondary biliary cirrhosis and (rat), 108:1183

Missense mutations genomic variations in precore/core gene of hepatitis B virus and, 108:310-tmig, 108:505

p53 protein in hepatocellular carcinoma and, 108:1176

Mitochondria

June 1995

cystic fibrosis transmembtane conductance regulator and (rat, human), 108:1016 fructose-l,6-biphosphate and (rat), 108:1785 liver cell necrosis and, 108:258-srr

Mitochondrial DNA (mtDNA) deletion, hepatic, in alcoholics, 108:193 Mitochondrial membrane permeability transition (MMPT), liver cell necrosis and, 108:258-srr Mitogenic properties, epidermal growth factor stability in gastric juice and, 108:92 Mitosis, hepatocellular DNA synthesis and (rat), 108:477 MK-678, cholangiocarcinoma and, 108:1908-rc Modular diets, role of, 108:1296-aga Monensin, cytochrome P4502B traffic and (rat), 108:1110

Monocyte-chemoattractant protein 1 (MCP-1), in inflammatory bowel disease, 108:40

SUBJECT INDEX 2003

Motility assay, kinesin and (rat), 108:824

Motoneurons, NO synthase in esophageal peristalsis and (rat), 108:367 M u c i n o u s t u m o r s , pancreatic cyst fluid analysis and, 108:958-tmig, 108:1230

Mononuclear cells Hsp60 expression and, 108:75 monocyte-chemoattractant protein 1 and, 108:40

Mononuclear phagocytes interleukin 4 in IBD and, 108:21, 108:284-e interleukin 10 in IBD and, 108:1434 Monosaccharides, intestinal permeability and, 108:1569-srr M o r t a l i t y rates childhood chronic intestinal pseudo-obstruction and, 108:1379 hereditary nonpolyposis colorectai cancer and, 108:1405 infection in bleeding cirrhotic patients and, 108:1828 nonmalignant chronic intestinal failure and, 108:1005, 108:1302-e polycystic liver disease and, 108:309-tmig, 108:487

Motility colon, hyperglycemia and, 108:309-tmig, 108:350 gallbladder, cholecystectomy and, 108:1332< intestinal, in childhood chronic intestinal pseudo-obstruction, 108:1379

108:850

Mucosal architectural alterations,

Na+-K+-adenosine lamlphosphatase,

in Crohn's disease, 108:376

ras-2 mutations in colon cancer and,

cystic fibrosis transmembrane conductance regulator and (rat, human), 108:1016 N A D P H , NO synthase in esophageal peristalsis and (rat), 108:367 N A D P H d i a p h o r a s e , NO in primate coiitis and (rhesus macaque), 108:705 NaHCO3, epidermal growth factor stability in gastric iuice and, 108:92 Nalgrexone, opioid binding in cholestasis and (rat), 108:1479 Nasoenteric tubes, technical review of, 108:1283-aga Nasogastric tube, Crohn's disease and, 108:957-tmig

108:1040

Natural killer (NK) ceils

Mucosal i m m u n i t y , to cryptosporidiosis, 108:624-tmig, 108:627

Mucosal r e p a i r , human spasmolytic polypeptide and, 108:108

Mucosal surface, colonic permeation of inulin and (rat), 108:12

Mucosal thickening, dietary ammonium-induced hypergastrinemia and (rat), 108:320 Multilumen tube, mesalamine microgranule delivery in, 108:1338-tmig, 108:1427

Multiparameter flow cytometry, K-

Monocytes inflammatory bowel disease and, 108:21, 108:284-e interleukin 10 in IBD and, 108:1434 monocyte-chemoattractant protein 1 in IBD and, 108:40 opioid binding in cbolestasis and (rat), 108:1479 TNF-o! and, 108:1337-tmig, 108:1453 Mononteric diets, role of, 108:1294-aga

flux, octreotide and (prairie dog), 108:1547 N a ÷ / H + exchange, hepatocellular, regulation of, 108:305-c Na+/HC03 - cotransport, pancreatic H+/HCO3 - secretion and (pig),

Multiple endocrine neoplasia type I : ( M E N - 1 ) , Zollinger-Ellison syndrome and, 108:1637

Multiple focal nodular hyperplasia, of liver, 108:1256-cr M u s c a r l n i c r e c e p t o r s , gallbladder and, 108:1329< Muscle tissue, Wilson's disease and, 108:885-cr M u s c u l a r i s p r o p r i a , colonic, IGF-1 and (rat), 108:644 Mutations, genomic variations in precore/ core gene of hepatitis B virus and, i08:310-tmig, 108:505 M y a l g i a s , mesalamine and, 108:1889-cr Mycobactegia, Hsp60 expression and, 108:75

Myeloperoxidase dexamethasone-/3-D-glucuronide and (rat), 108:1688 pancreatitis and (rat), 108:1855 Myenteric denervation, myenteric, calcium metabolism and (rat), 108:1629 Myenteric plexus, NO in primate colitis and (rhesus macaque), 108:705 Myocardial muscle, Wilson's disease and, 108:885-cr Myoelectric complexes, colonic, neural control of (mouse), 108:1371 Myosin, bile canalicular contraction and, 108:841

Na + cryprosporidiosis and (piglet), 108:1030 fecal excretion of, 108:752

interferon c~ and (rat), 108:1192 SF-25 monoclonal antibody and (nude mice), 108:172

Necrosis hepatic, immunostaining for membrane attack complex of complement and, 108:309-tmig, 108:495 HIV-associated necrotizing cholangitis and, 108:247-cr IL-10 in pancreatitis and, 108:1917-rc liver cell, 108:252-srr Necrotizing cholangitis, HIV-associated, Septata intestinalis in, 108: 247-cr N e c t u r u s gastric mucosa, pHi regulation and, 108:999 Negative feedback regulation, of cholesterol 7oe-hydroxylase, 108:533 Neoangiogenesis, in chronic viral hepatitis, 108:231

Neomycin intestinal permeability and, 108:1574-srr liver injury by alcohol blocked by (rat), 108:218 Neonates, liver development in, pancreatic enzymes and, 108:1236 N e u r a l c i r c u i t , brain stem, nitric oxide synthase in (rat), 108:367 N e u r a l r e f l e x e s , glucose effects on colon motility and, 108:350 Neurofilament proteins, enteric inhibitory neurons and, 108:554-srr Neurogenic control, of myoelectric complexes (mouse), 108:1371 N e u r o g e n i c i n f l a m m a t i o n , of intestine (rat), 108:295-ss

2004

SUBJECT INDEX

Neuromuscular f u n c t i o n , glucose effects on colon motility and, 108:350

Neurons enteric neurotransmitters and, 108:554-srr NO synthase in esophageal peristalsis and (rat), 108:367 rectoanal inhibitory reflex and, 108:1700 Neuropathy, glucose effects on colon motility and, 108:309-tmig, 108:350 Neurotensin, amylase inhibition and (dog), 108:1221 Neurotoxins, histamine in duodenal bicarbonate secretion and (rabbit), 108:1676

Neurotransmitters enteric, 108:554-srr ileal crypts and (mouse), 108:1345 inhibitory, colonic myoelectric complexes and (mouse), 108:1371 Neutrophil-activating cytokine, in HT-29 cells, 108:653 Neutrophil infiltrates, Helicobacterpylori infection and, 108:65 Neutrophils, opioid binding in cholestasis and (rat), 108:1479

New Titles Annual of Gastrointestinal Endoscopy, 7th ed., 108:302 Atlas of Gastrointestinal Pathology, 108:302 BaiIliere's Clinical Gastroenterology. International Practice and Research. Frontiers of Treatment in Gastroenterology, Volume 8, No. 2, June 1994, 108:949 Case Atlas of Gastroenterology, 108:1952 Color Atlas/Text of Advanced Laparoscopyfor Surgeons, 108:1952 Current Studies in Hematology and Blood Transfusion. No. 6I: Hepatitis C Virus, 108:616 Electrogastrography: Principles and Applications, 108:616 Gastrointestinal TNM Cancer Staging by Endosonography, i 08:1328 Inflammatory Bowel Disease, 108:1328 Inflammatory Bowel Disease-- 1994, 108:1952 Liver Disease in Children, 108:1328 Notes on Medical Bacteriology, 108:1604 Psychosomatics, Psychoanalysis, and Inflammatory Disease of the Colon, 108:1952 Radiation and the Gastrointestinal Tract, 108:1604 Retroperitoneum and Intestine. 2nd ed. (from the series Guides to Clinical Aspiration Biopsy), 108:302 Surgical Infections, 1st ed., 108:949 Viral Infections of the Gastrointestinal Tract. Second Edition. Revised and Expanded, 108:949 Your Gut Feelings: Revised and Updated Edition, 108:302

GASTROENTEROLOGY Vol. 108, No. 6

N H 3 g a s t r o p a t h y , Helicobacterpylori and (rat), 108:309-tmig, 108:320 Nicotine, ileal crypts and (mouse), 108:1343

Nifedipine colonic myoelectric complexes and (mouse), 108:1371 myenteric denervation of jejunum and (rat), 108:1629

Nitric oxide (NO) colonic myoelectric complexes and (mouse), 108:1371 enteric inhibitory neurons and, 108:554srr

ethanol-induced gastric mucosai injury and (rat), 108:58 hepatic reperfusion injury and (rat), 108:463, 108:603-e hepatocellular signal transduction and, 108:841 histamine ileal vasodilatory mechanisms and (guinea pig), 108:712 pancreas and (cat), 108:1215 pancreatitis and (rat), 108:1855 pepsinogen secretion and (guinea pig), 108:1709 primate colitis and (rhesus macaque), 108:705

Nitric oxide synthase esophageal peristalsis and (rat), 108:367 portal hypertension and (rat), 108:1487 N i t r i t e , hepatic reperfusion injury and (rat), 108:463 Nitrogen, dietary stimulation of bifodobacteria and, 108:975 Nitrovasodilators, secondary biliary cirrhosis and (rat), 108:1183 Nocodazole, cytochrome P4502B traffic and (rat), 108:1110 NOLA, colonic myoelectric complexes and (mouse), 108:1371 Non-A, non-B (NANB) hepatitis, viremia in hepatitis E infection and, 108:225 Nonabsorptive cells~ genetic hemochromatosis and, 108:2-tmig, 108:208 Nonalcoholic steatohepatitis, prognosis in, 108:1607-c Noncardiac p a i n , esophageal sensitization in, 108:311

Nondegraded radiolabeled chelates, intestinal permeability and, 108:1569-srr

Nonelemental formulas, for Crohn's disease, 108:1056

Nonspecitic gastroenteritis, intestinal permeability and, 108:1574-srr

Nonsteatorrhea stools, fecal consistency in diarrhea and, 108:1729

Nonsteroidal anti-inflammatory drugs (NSAIDs) gastropathy and (rat), 108:393 intestinal permeability and, 108:1573-srr sporadic colorectal adenomas and, 108:1310-e Noradrenaline, ileal crypts and (mouse), 108:1345

Norepinephrine midget carcinoid flush and, 108:743 preascitic cirrhosis and, 108:1820

Northern blot analysis angiogenesis in pancreatic cancer and (Syrian hamster), 108:1526 fibrinogen/fibrin deposition and (rat), 108:1124 IGF-1 binding sites in colitis and (rat), 108:644 IL-8 in HT-29 cells and, 108:653 Notices, 108:307, 108:621, 108:955, 108:1335, 108:1612, 108:1964

Nuclear labeling follistatin and (rat), 108:1136 hepatocellular DNA synthesis and (rat), 108:477

Nucleation cholesterol crystals and, 108:1882 octreotide and (prairie dog), 108:1547 Nucleus ambiguus, NO synthase in esophageal peristalsis and (rat), 108:367 Nucleus of the solitary tract, NO synthase in esophageal peristalsis and (rat), 108:367 Nude mice, inhibition of liver metastases of colon cancer in, 108:172 N u t r i t i o n a l support teams, enteral nutrition and, 108:1281-aga

Oatmeal, [13]acetate breath test for gastric emptying and, 108:1048

Obesity amylase inhibition and (dog), 108:1221 intestinal permeability and, 108:1575-srr Occlusion, TIPS and, 108:1143

Octreotide cholangiocarcinoma and, 108:1908-rc gallbladder absorption and (prairie dog), 108:1547 HIV-associated diarrhea and, 108:1616tmig, 108:1753, 108:1939-e Ocular lesions, colonic sarcoidosis and, 108:1556-cr

2',5'-Oligoadenylate synthetase, interferon ~ and, 108:165,108:1192

Oligoft'ugtose, in dietary stimulation of bifodobacteria, 108:958-tmig, 108:975 Oligomerlc diets, role of, 108:1294-aga Oligosaccharides, intestinal permeability and, 108:1368-srr

June 1995

Omeprazole epidermal growth factor stability in gastric juice and, 108:92 erosive esophagitis and, 108:613-ss gastric ethanol metabolism and (rat), 108:737 gastroesophageal reflux disease and, 108:303-c, 108:1958< Helicobacterfelis and, 108:1386 Helicobacter pylori and, 108:1338-tmig, 108:1412 hypergastrinemia in colon cancer and (rat), 108:1068 pancreastatin and (rat), 108:1445 Oncogenes, premalignant colon lesions and, 108:108:117, 291-e Oocysts, fecal, AIDS-related cryptosporidiosis and, 108:1075 Opioids, in cholestasis, 108:1479, 108:1582-vodd Orange j u i c e , heartburn and, 108:2tmig, 108:125 O r n i t h i n e , refrigerated donor livers and, 108:1510 Oropharyngeal pressure, tongue force modulation and, 108:1418

Orthotopic liver transplantation, for chronic hepatitis with common variable immunodeficiency, 108: 879-cr Osmolality, of popular beverages, heartburn and, 108:2-tmig, 108:125 O s m o l a r i t y , intestinal permeability and, 108:1570-srr Osmosis, hepatic glucuronidation and (rat), 108:183 Osmotic fluid retention, intestinal permeability and, 108:1570-srr O s t e o c a l c i n , osteopenia and, 108:417 Osteomalacia, in inflammatory bowel disease, 108:417 Osteopeuia, in inflammatory bowel disease, 108:417 O n a b a i n , gastric mucosal phi regulation and (Necturus, 108:999 Oxidative damage, hepatic mitochondrial DNA deletion in alcoholics and, 108:193 Oxidative stress, liver cell necrosis and, 108:255-srr

Oxygen hepatic reperfusion injury and (rat), 108:463 liver cell necrosis and, 108:260-srr theophylline clearance in cirrhosis and (rat), 108:1504

Oxygen radicals liver reimplantation and (rat), 108:1167, 108:1317-e photodynamic therapy for esophageal cancer and, I08:310-tmig, 108:337

SUBJECT INDEX

Oxygen tension, liver injury by alcohol blocked by antibiotics (rat), 108:218

31p magnetic resonance spectroscopy, in chronic alcohol abusers, 108:776

p53 protein colorectal aberrant crypt foci and, 108:434 European hepatocellular carcinoma and, 108:1176 p53 gene mutation p , p53 protein accumulation and, 108:1176 p75 receptor, TNF-c~, in hepatitis B virus, 108:1337-tmig, 108:1453

Pain abdominal, 108:242-cr, 108:947-br, 108:1256-cr, 108:1556-cr, 108:1576-srr noncardiac, esophageal sensitization in, 108:311 perception, sexual abuse history and, 108:1945-ss

Pancreas amino acid transport and, 108:888-srr amylase inhibition and (dog), 108:1221 cancer angiogenesis and (Syrian hamster), 108:1526 c~6-integrin receptor in, 108:523 Crohn's disease and, 108:i246-cr cyst fluid analysis and, 108:958-tmig, 108:1230 diseases of, 108:615-br enzymes, in liver development, 108:1236 exocrine, pancreatic polypeptide and (rat), 108:1517 H+/HCO3- secretion and (pig), 108:850 nitric oxide and (cat), 108:1215 transforming growth factor a and, 108:573-srr Pancreastatin, circulating, stomach ECL cells and (rat), 108:1445

Pancreatic endocrine tumors (PETs), Zollinger-Ellison syndrome and, 108:1637

Pancreatic polypeptide, microinjection of into dorsal motor nucleus (rat), 108:1517

Pancreatitis alcoholic, 108:297-ss amino acid transport and, 108:903-srr cerulein and (rat), 108:1855, 1863 interleukin 10 and, 108:1917-rc latent TGF-/31-binding protein and, 108:1873 nitric oxide and (rat), 108:1855 TGF-/51 and, 108:1873 Paneth cells, ileaI crypts and (mouse), 108:1345

Papillomavirus esophageal papilloma and, 108:550-cr

2005

esophageal squamous cell carcinoma and, 108:1605-c Paracellular b a r r i e r , pancreatitis and (rat), 108:1863 P a r a i n f l u e n z a v i r u s , Crohn's disease and, 108:1396 Parathyroid hormone (PTH), osteopenia and, 108:417

Parenchyma hypoechoic nodular pattern and, 108:1778 small heparocellular carcinoma and, 108:768

Parenteral nutrition childhood chronic intestinal pseudo-obstruction and, 108:1379 glutamine and, 108:1961-c Paromomycin, AIDS-related cryptosporidiosis and, 108:957-tmig, 108:1075 Patient r e p o r t i n g , reliability of, I08:1959<

Pearson bone marrow-pancreas syndrome, hepatic mitochondrial DNA deletion in alcoholics and, 108:193 Pentane, liver cell necrosis and, 108:257srr

Pentasa Crohn's disease and, 108:310-tmig, 108:345, 108:1936-e oral microgranules, intestinal delivery of, 108:1338-tmig, 108:1427 Pentoxifylline, polymorphonuclear leukocyte margination and (rat), 108:393

Pepsin epidermal growth factor stability in gastric juice and, 108:92 esophageal mucosal injury and, 108:1897srr fetal gastric mucosa and, 108:1650 human spasmolytic polypeptide and, 108:108 Pepsinogen, leukotrienes and (guinea pig), 108:1709

Peptide tyrosine-immunoreactive cells, in GI mucosa and (db/db mice), 108:967 Peptide YY, amylase inhibition and (dog), 108:1221

Perception gastric distension and, 108:330 gut distension and, 108:680 irritable bowel syndrome and, 108:636, 108:927-e pain, sexual abuse history and, 108: 1945-ss rectal distension, glucose and, 108:1616tmig, 108:1700 symptom, gastroesophageal reflux disease and, 108:1739

2006

SUBJECT INDEX

Percutaneous intervention, TIPS and, 108:1143 Perforation, esophageal, gastrografin for, 108:618-c Perf~sed sleeve sensor, gastroesophareal reflux in ambulant subjects and, 108:83 Pericentral necrotic areas, hepatic (rat), 108:1124 Perinuclear staining pattern, antineutrophil cytoplasmic antibodies and, 108:1159 Periorbital swelling, colonic sarcoidosis and, 108:1556-cr

Peripheral blood lymphocytes, VCAM-1 in chronic viral hepatitis and, 108:231

Peripheral monocytes inflammatory bowel disease and, 108:21, 108:284-e interleukin 10 in IBD and, 108:1434 P e r i p o r t a l h e p a t i t i s , autoimmune hepatitis and, 108:1159 Perisinusoidal c e l l s , liver disease and, 108:145

Peristaltic reflex esophageal, nitric oxide synthase in (rat), 108:367 glucose effects on colon motility and, 108:350

Peglneability colonic, inulin and (rat), 108:12 intestinal Crohn's disease and, 108:2-tmig, 108:132 cryptosporidiosis and (piglet), 108:1030 flow rate and, 108:983 overview of, 108:1566-srr paracellular, pancreatitis and (rat), 108:1863 ratios, lactulose/mannitol (cat, human, rodent), 108:687 Permselectivity, colonic permeation of inulin and (rat), 108:12 Peroxyl radicals, liver cell necrosis and, 108:257-srr P e r o x y n i t r i t e , hepatic reperfusion injury and (rat), 108:463, 108:603-e

pH epidermal growth factor stability in gastric juice and, 108:92 esophageal mucosal injury and, 108:1897srr esophageal sensitization in noncardiac pain and, 108:311 gastroesophageal reflux in ambulant subjects and, 108:83 heartburn and, 108:2-tmig, 108:125 Helicobacter py lori and, 108:1338-tmig, 108:1412

GASTROENTEROLOGY Vol. 108, No. 6

pancreatic H+/HCO3 secretion and (pig), 108:850 T M

pHi gastric mucosal (Necturus), 108:999 HCI in esophageal cells and (rabbit), 108:662

Phagocytosis inflammatory bowel disease and, 108:21 interleukin 10 in IBD and, 108:1434 P h a r y n g e a l water stimulation, of lower esophageal sphincter, 108:441 P h a r y n x , gastroesophageal reflux in ambulant subjects and, 108:83 Phenolphthalein, in fecal Na ÷ and K + excretion, 108:752

Phenotype chronic viral hepatitis and, 108:157 intestinal permeability in Crohn's disease and, 108:132 Phenylephrine, atrial natriuretic peptide in hepatic vasodilation and (rat), 108:803 P h l o r i z i n , cryptosporidiosis and (piglet), 108:1030

Phorbol myristate acetate (PMA), IL-8 in HT-29 cells and, 108:653

Phosphate cholangiocarcinoma and, i08:1908-rc chronic alcohol abuse and, 108:776 osteopenia and, 108:417 Phosphatidylcholine, gallbladder emptying and, 108:1882 Phosphodiesterase i n l ~ i t o r , coIonic permeation of inulin and (rat), 108:12 Phosphodiesters, chronic alcohol abuse and, 108:776

PhosphoHpids apoptosis and, 108:304-c HepG2 cells and, 108:515 Phosphomonoesters, chronic alcohol abuse and, 108:776

Phosphorylation fructose-l,6-biphosphate and (rat), 108:1785 IL-8 in HT-29 ceils and, 108:653 Photodynamic therapy, for esophageal cancer, 108:310-tmig, 108:337, 108:593-e PhotomultipHer tube, free radical production after cold storage and (rat), 108:1167 Phylogenetic analysis, HCV genotyping and, 108:1088 Physical a c t i v i t y , gastroesophageai reflux in ambulant subjects and, 108:83 Physiology, of gastrointestinal tract, 108:948-br

Plasma liver injury by alcohol blocked by antibiotics (rat), 108:218

quinolinic acid and, 108:818

Plasma membrane, hepatocyte, cytochrome P4502B traffic and (rat), 108:1110

Platelet-activating factor (PAF) in eosinophil migration across epithelium, 108:409 receptors, desensitization of (guinea pig), 108:1666

Platelet-derived growth factor ( P D G F ) , A and B, liver disease and, 108:145 Platelet-poor plasma, midget carcinoid flush and, 108:743 PLC/PRF/5 cells, activin-follistatin system in, 108:834 P l e u r a l e f f u s i o n , polycystic liver disease and, 108:487

Pneumatosis cystoides intestinalis, breath H2 excretion and, 108:1560-cr

Pneutnonia, liver transplantation for chronic hepatitis with common variable immunodeficiency and, 108:879-cr Point mutations, p53 protein in hepatocellular carcinoma and, 108:1176

Policy and Position Statement American Gastroenterological Association policy statement on the use of medical practice guidelines by managed care organizations and insurance carriers, 108:925 Polycystic liver disease, liver resection and cyst fenestration in, 108:309-tmig, 108:487 Polyethylene glycol (PEG), intestinal permeability and, 108:1568-srr

Polymerase chain reaction (PCR) angiogenesis in pancreatic cancer and (Syrian hamster), 108:1526 bacterial colonization of cholesterol gallstones and, 108:624-tmig changing prevalence of HCV genotypes and, 108:581-rc colorectal aberrant crypt foci and, 108:434 endothelin receptors and (guinea pig), 108:51 hepatic mitochondrial DNA deletion in alcoholics and, 108:193 hepatitis B virus and, 108:1810 hepatitis C virus and, 108:789 hepatitis delta virus and, 108:623-tmig, 108:796 hepatitis E virus and, 108:225 IL-10 in IBD and, 108:1434 IL-10 in pancreatitis and, 108:1917-rc K-ras-2 mutations in colon cancer and, 108:1040 monocyte-chemoattractant protein 1 in IBD and, 108:40

June 1995

NO in primate colitis and (rhesus macaque), 108:705 TGF-~I and, 108:1873

Polymeric diets Crohn's disease and, 108:1056 role of, 108:1294-aga

Polymorphonuclear leukocyte (PMN) m a r g i n a t i o n , NSAID gastropathy and (rat), I08:393 Polymyxin B, liver injury by alcohol blocked by (rat), 108:218 Polypectomy, malignant colorectal polyps and, 108:1615-tmig, 108:1657 Polypoid mass, Barretts esophagus and, 108:1894-cr

Polyps hereditary nonpolyposis colorectal cancer and, 108:1337-tmig, 108:1405, 108:1590-e malignant colorectal, 108:1615-tmig, 108:1657 occurrence and recurrence, 108:309-tmig, 108:402 pyogenic granuloma in Barrett's esophagus and, 108:1894-cr sporadic colonic, sulindac and, 108:1083, 108:1311-e ulcerative colitis and, 108:1361

Polyunsaturated fatty acids (PUFAs), liver cell necrosis and, 108:257-srr

PolyvinylpyrroHdine, intestinal permeability and, 108:1569-srr Pore, colonic, colonic permeation of inulin and (rat), 108:12 P o r p h y r i n , in photodynamic therapy for esophageal cancer, 108:310- _mig, 108:337 Portacaval anastomosis, brain edema and intracranial hypertension after (rat), 108:1097 Portal hemodynamics, hepatic arterial resistance and, 108:1152

Portal hypertension intestinal permeability and, 108:1576-srr nitric oxide synthase and (rat), 108:1487 secondary biliary cirrhosis and (rat), 108:1183 TNF-c~ and (rat), 108:761

Portal hypertensive gastropathy, antral vascular ectasia and, 108:138 P o r t a l p r e s s u r e , endothelin 1 and (rat), 108:1842 Portal tracts, neoangiogenesis in, 108:231 Portal vein blood, fl-carotene absorption and (ferret), 108:719 Portal vein thrombosis, hepatic arterial resistance and, 108:1152 Positive feedback mechanism, leu-

SUBJECT INDEX

2007

Prodrug, dexametbasone (rat), 108:1688 Proinllammatory cytokines

kotriene C4 synthesis and (rat), 108:1793 Postcaplllary venules, radiation-induced microvascular dysfunction and (rat), 108:1761 Postcibal e p i g a s t r i c f u l l n e s s , gastric distension and, 108:330 Posttransplant complications, refrigerated donor livers and, 108:1337-tmig, 108:1510

inflammatory bowel disease and, 108:21, 108:284-e, 108:1338-tmig, 108:1434 polymorphonuclear leukocyte margination and (rat), 108:393 Prointlammatory mediators, alcohol-induced liver injury and (rat), 108:1-tmig

Potassium chloride

Proliferating cell nuclear antigen

intestinal permeability and, 108:1569-srr myenteric denervation of jejunum and (rat), 108:1629 Preascitic cirrhosis, sodium handling and, 108:1820 Precore/core gene, of hepatitis B virus, 108:310-tmig, I08:505

Prednisone colonic sarcoidosis and, 108:1556-cr ulcerative colitis and, 108:1889-cr Premotor neurons, NO synthase in esophageal peristalsis and (rat), 108:367 Preservation f l u i d , refrigerated donor livers and, 108:1337-tmig, 108:1510 Pressure-volume relationships, rectoanal inhibitory reflex and, 108:1700

Prevention and control strategies, E. co/i O157:H7 and, 108:I928-aga

Primary biliary cirrhosis

(PENAL), TGF-~ and, 108:1963-c

ProHthogenic factors, octreotide and (prairie dog), 108:1547

Prooxidants, liver cell necrosis and, 108:255-srr

Propionibacteriaceae, bacterial colonization of cholesterol gallstones and, 108:624-tmig, 108:860

Prostaglandin E2 (PGEa) colonic permeation of inulin and (rat), 108:12 duodenal HCO 3 secretionand, 108:102 histamine in duodenal bicarbonate secretion and (rabbit), 108:1676

Prostaglandins hyperglycemia-evoked gastric slow-wave dysrhythmias and, 108:727 platelet-activating factor receptors and (guinea pig), 108:1666 Protease inhibitors, refrigerated donor livers and, 108:1337-tmig, 108:1510

carbonic anhydrase antibodies and, 108:1802 colchicine and, 108:1199, 108:1470, 108:1592-e pyruvate dehydrogenase and, 108:1802 UGT and, 108:1464 ursodeoxycholic acid and, 108:1470, 108:1592-e Primary dual defect, in intrahepatic calculi, 108:1534

Protein

Primary sclerosing cholangitis

Protein tyrosine kinases

antineutrophil cytoplasmic antibodies and, 108:1159 carbonic anhydrase antibodies and, 108:1802 cholangiocarcinoma in, serum tumor markers for, 108:865 colchicine and, 108:1199 HLA class II and, 108:870, 108:937-e Primate c o l i t i s , nitric oxide and (rhesus macaque), 108:705 Probe molecules, intestinal permeability and, 108:1568-srr

interleukin 8 induction and, 108:653 premalignant colon lesions and, 108:117, 108:291-e Proteolysis, refrigerated donor livers and, 108:1337-tmig, 108:1310, 108:1594-e

Procollagen colchicine and, 108:1470 liver disease and, 108:145 ursodeoxycholic acid and, 108:1470 Proctocolitis, glutaraldehyde and, 108:1250-cr

amylase inhibition and (dog), i08:1221 genetic hemochromatosis and, 108:208 octreotide and (prairie dog), 108:1547 Protein kinase A (PKA), interleukin 8 induction and, 108:653

Protein kinase C (PKC), interleukin8 induction and, 108:633

ProteinAosing enteropathy, intestinal permeability and, 108:1576-srr

Prothrombin time primary sclerosing cholangitis and, 108:1199 refrigerated donor livers and, 108:1510 Provisional m a t r i x , fibrinogen and (rat), 108:1124 Provocation tests, esophageal sensitization in noncardiac pain and, 108:311 Pruritis cholestasis and, 108:1582-vodd colchicine and, 108:1470 ursodeoxycholic acid and, 108:1470

2008

SUBJECT INDEX

P - s e l e c t i n , radiation-induced microvascular dysfunction and (rat), 108:1761 Pseudoachalasia, sphincter of Oddi dysfunction and, 108:242-cr Pseudocysts, pancreatic cyst fluid analysis and, 108:958-tmig, 108:1230 Pseudomonas aeruginosa, colonization of cholesterol gallstones and, 108:861 Pseudorabies v i r u s , NO synthase in esophageal peristalsis and (rat), 108:367 Psychiatric patients, intestinal permeability and, 108:1576-srr Psyllium, fecal consistency in diarrhea and, 108:1729 P u l m o n a r y f o r m u l a s , role of, 108:1295-aga P u l m o n a r y sarcoidosis, intestinal permeability and, 108:1576-srr Pyogenic granuloma, in Barrett's esophagus, 108:1894-cr P y r i l a m J n e , histamine ileal vasodilatory mechanisms and (guinea pig), 108:712 Pyruvate dehydrogenase, primary biliary cirrhosis and, 108:1802

Quality of life home parenteral nutrition and, 108: 1302-e polycystic liver disease and, 108:487 Quantification techniques, GI tract endocrine cells and (db/db mice), 108:967 Quantitative endoscopy, of Barrett's esophagus, 108:360 Quasispecies, of hepatitis C virus, 108:623-tmig, 108:789 Q n i n o l l n i c a c i d , in hepatic encephalopathy, 108:818

Radiation, microcirculation and (rat), 108:1761

Radioenzymatic assay, midget carcinoid flush and, 108:743

Radiography HIV-associated necrotizing cholangitis and, 108:247-cr sphincter of Oddi dysfunction and, 108:242-cr

Radioimmunoassay (RIA) atrial natriuretic peptide in cirrhosis and (rat), 108:1496 epidermal growth factor stability in gastric juice and, 108:92 pancreastatin and (rat), 108:1445 Radioimmunoprecipitation, ~6-integrin in pancreatic cancer and, 108:523

GASTROENTEROLOGY Vol. 108, No. 6

Radioisotope assay, Grgsbeck-Imerslund disease and, 108:1622 Radiolabeled chelates, intestinal permeability and, 108:1569-srr

Radiological shunt evaluation, TIPS and, 108:1143

Radiology, interventional, at crossroads, 108:951-c

Radioscintigraphy, [~3]acetate breath test for gastric emptying and, 108:1048 Radiotherapy, photodynamic therapy for esophageal cancer and, 108:310-tmig Raffinose, intestinal permeability and, 108:1569-srr

Ranitidine gastroesophageal reflux disease and, 108:303-c, 108:1958-c Helicobacterfdis and, 108:1386 histamine ileal vasodilatory mechanisms and (guinea pig), 108:712 hypergastrinemia in colon cancer and (rat), 108:1068 pancreastatin and (rat), 108:1445

Rapid Communications The changing relative prevalence of hepatitis C virus genotypes: evidence in hemodialyzed patients and kidney recipients, 108:581 Correction of the cystic fibrosis defect by gene complementation in human intrahepatic biliary epithelial cell lines, 108:584 Human cholangiocarcinomas express somatostatin receptors and respond to somatostatin with growth inhibition, 108:1908 Interleukin 10 prevents necrosis in murine experimental acute pancreatitis, 108:1917

Rapid filtration techniques butyrate uptake and (rat), 108:673 hepatic glucuronidation and (rat), 108:183 Reactive oxygen species, hepatic mitochondrial DNA deletion in alcoholics and, 108:193

Rebleeding infection in cirrhosis and, 108:1828 TIPS and, 108:958-tmig, 108:1143

Receptors endothelin, 108:51 epidermal growth factor, 108:566-srr galanin, 108:3 histamine, 108:712 c~6-integrin, 108:523 macrophage mannose, 108:21 muscarinic, 108:1329-c opioid, 108:1479 pain, 108:311 platelet-activating factor, 108:1666 stretch, 108:311

soluble TNF-a (rat), 108:1616-tmig, 108:1849 somatostatin, 108:1908-rc tumor necrosis factor a, 108:1337-tmig, 108:1453

Recombinant immunoblot assay 2, changing prevalence of HCV genotypes and, 108:581-rc Rectoanal inhibitory reflex, hyperglycemia and, 108:1616-tmig, 108:1700

Rectum colonic sarcoidosis and, 108:1556-cr surgery of, 108:301-br

Recurrence colorectal adenoma and, 108:309-tmig, 108:402 Crohn's disease and, 108:310-tmig, 108:345, 108:376, 108:1617 small heparocellular carcinoma and, 108:768 Recurrent syndrome, intestinal permeability and, 108:1576-srr Redox potential, hepatic, chronic alcohol abuse and, 108:776

Red spots antral vascular ectasia and, 108:138 portal hypertensive gastropathy and, 108:138 Red wine, heartburn and, 108:2-tmig Re-epitheHalization, human spasmoiytic polypeptide and, 108:108

Reflectance spectrophotometry, NO synthase in portal hypertension and (rat), 108:1487 R e f l e x r e s p o n s e s , gut distension and, 108:680

Reflux esophagitis heartburn and, 108:125 omeprazole for, 108:613-ss

Refractory reflux esophagitis, omeprazole for, 108:613-ss

Refrigeration, of donor livers, 108:1337tmig, 108:1510

Regurgitation, effortless, rumination syndrome and, 108:957-tmig, 108:1024 Relatives, intestinal permeability in Crohn's disease and, 108:2-tmig, 108:132 Relaxation t r a i n i n g , in gastroesophageal reflux disease, 108:619-c Renal failure formulas, role of, 108:1295-aga Reoxygenation i n j u r y , liver cell necrosis and, 108:260-srr

Reperfnsion free radical production after cold storage and (rat), 108:1167, 108:1317-e fructose-l,6-biphosphate and (rat), 108:1785

June 1995

SUBJECT INDEX

Resin, in fecal Na * and K + excretion,

Ringer's solution, octreotide and (prai-

108:752 R e s i n c a s t i n g , Crohn's disease and, 108:911-srr Respiratory control ratio, fructose1,6-biphosphate and (rat), 108:1785 Respiratory syncytial v i r n s , Crohn's disease and, 108:1396

rie dog), 108:1547 RNA v i r u s e s , quasispecies and, 108:623tmig R o l l i n g , leukocyte, radiation-induced microvascular dysfunction and (rat), 108:1761 R o t a v i r u s i n f e c t i o n , intestinal permeability and, 108:1573-srr R u m i n a t i o n s y n d r o m e , clinical features of, 108:957-tmig, 108:1024 R - w a v e s , rumination syndrome and, 108:957-tmig

Respirography deglutitive vocal cord closure and, 108:1357 lower esophageal sphincter tone and, 108:441 Rest p e r i o d s , gastroesophageal reflux in ambulant subjects and, 108:83

Restriction fragment length polymorphism (RFLP) chronic viral hepatitis and, 108:157 colorectal aberrant crypt loci and, 108:434 R e t i c u l i n , intestinal permeability and, 108:1573-srr R e t i n o l , ~-carotene conversion to (ferret), 108:719

Reverse-transcription polymerase chain reaction angiogenesis in pancreatic cancer and (Syrian hamster), 108:1526 changing prevalence of HCV genotypes and, 108:581-rc endothelin receptors and (guinea pig), 108:51 hepatitis delta virus and, 108:623-tmig, 108:796 hepatitis E virus and, 108:l-tmig, 108:225 IL-10 in IBD and, 108:1434 IL- 10 in pancreatitis and, 108:1 c 17-rc monocyte-chemoattractant protein 1 in IBD and, 108:40 NO in primate colitis and (rhesus macaque), 108:705 TGF-fll and, 108:1873 RGDS, ~6-integrin in pancreatic cancer and, 108:523 Rhabdomyolysis, acute, in Wilson's disease, 108:885-cr L-Rhamnose, intestinal permeability and, 108:1569-srr Rhinoconjunctivitis, intestinal permeability and, 108:1575-srr Rhizotomy, anorectal function and, 108:990 R h o d a m i n e p h a l l o i d i n , pancreatitis and (rat), 108:1863

Rl~bonuclease protection assay, atrial natriuretic peptide in cirrhosis and (rat), 108:1496

Rt~bosomal RNA (rRNA) sequence analysis, bacterial colonization of cholesterol gallstones and, 108:860

Sacral posterior rhizotomy, anorectal function and, 108:990 Saline esophageal sensitization in noncardiac pain and, 108:311 gastric distension and, 108:330 platelet-activating factor receptors and (guinea pig), 108:1666 S a l i v a r y g l a n d s , zymogenic cell differentiation and (transgenic mice), 108:447 S a l m o n e l l a spp., intestinal permeability and, 108:1574-srr S a n d o s t a t i n , HIV-associated diarrhea and, 108:1939-e S a r a f o t o x i n 6 c , endothelin receptors and (guinea pig), 108:51

Sarcoidosis colonic, 108:1556-cr pulmonary, 108:1576-srr

Sarcoplasmic reticulum, myenteric denervation of jejunum and (rat), 108:1629

Scanning electron microscopy (SEM), Crohn's disease and, 108:376, I08:9I 1-srr S c a r r i n g , liver disease and, 108:145 Scatter parameters, K-ras-2 mutations in colon cancer and, 108:1040 Schizophrenia, intestinal permeability and, 108:1576-srr

Scintigraphy [13]acetate breath test for gastric emptying and, 108:1048 duodenogastric reflux and, 108:1902-srr

Sclerotherapy papilloma virus infection and, 108:550-cr variceal bleeding and, 108:958-tmig Screening programs, hereditary nonpolyposis colorectal cancer and, 108:1337-tmig, 108:1405, 108:1590-e Secondary biliary cirrhosis, gastric microcirculation and (rat), 108:1183 Second messengers, nitric oxide and (cat), 108:1215

Secretin

2009

nitric oxide and (cat), 108:1215 pancreatic H+/HCO3 - secretion and (pig), 108:850 Secretomotor neurons, chemistry of, 108:558-srr Secretory response, cholera toxin and (rat), 108:2-tmig, 108:34 Sedimentation rate, osteopenia and, 108:417 Seizures, quinolinic acid and, 108:818

Selected Summaries Absorptive hyperemia, 108:1599 Accuracy of endoscopic measurements: sizing up the problem, 108:941 Alcoholic pancreatitis: unraveling the mystery, 108:297 Angiostatin: candidate for molecule of the year!, 108:1946-ss Antioxidants and colonic neoplasia: an absence of ACE inhibition, 108:1322 Aspirin versus colonoscopy in the reduction of carcinoma of the colon, 108:612 Cancer in ulcerative colitis: more from St. Mark's, 108:1321 Cyclosporine and inflammatory bowel disease: still more questions, 108:943 Helicobacter pylori and gastric lymphoma, I08:610 Long-term treatment of erosive esophagitis with omeprazole: does it work?, 108:613 Magnetic resonance cholangiography: a field with attraction, 108:1948 Management of patients with gastric carcinoid tumors, 108:296 Managing dyspepsia: is prompt endoscopy the way to go?, 108:1324 Mapping a strategy for curing hepatitis C, 108:945 Neurogenic inflammation in the intestine, 108:295 A newly recognized source of Escherichia coli 0157-H7 infections, 108:1597 The reliability of noninvasive tests for celiac disease, 108:608 Sexual abuse and gastrointestinal disease, 108:1945 You may not be what you eat, I08:299 Zollinger-Ellison syndrome: surgery should still play an important role in its management, 108:1600 S e l f - l i m l t e d c o l i t i s , Hsp60 expression and, 108:75 Semisolid test meals, [13]acetate breath test for gastric emptying and, 108:957-tmig, 108:1048 Sensing bulbs, tongue force modulation and, 108:1418 Sensory afferent neurons, secondary biliary cirrhosis and (rat), 108:1183

2010

SUBJECT INDEX

Sepsis, intestinal permeability and, 108:1576-srr Septa, fibrotic (rat), 108:1124 Septata intestinalis, HIV-associated necrotizing cholangitis and, I08:247-cr S e q u e n c i n g analyses, colorectal aberrant crypt loci and, 108:434

Serotonin GI tract endocrine ceils and (db/db mice), 108:967 midget carcinoid flush and, 108:743 Serum, TNF-o: in HBV and, 108:1337tmig, 108:1453 S e r u m t u m o r m a r k e r s , for cholangiocarcinoma in primary sclerosing cholangitis, 108:865 S e w a g e water, hepatitis E virus infection and, 108:223 Sexual abuse, gastrointestinal disease and, 108:1945-ss S F - 2 5 m o n o c l o n a l antibody, inhibition of colon cancer liver metastases and (nude mice), 108:172 Shigella sonnei, swimming-associated outbreak and, 108:1597-ss

Short-chain fatty acids colonic epithelium and (rat), 108:673 dietary stimulation of bi£odobacteria and, 108:975

Short-circuit current cryptosporidiosis and (piglet), 108:1030 octreotide and (prairie dog), 108:1547

GASTROENTEROLOGY Vol. 108, No. 6

risk for intrahepatic recurrence of, 108:768

Small i n t e s t i n e AIDS-related cryptosporidiosis and, 108:957-tmig amino acid transport and, 108:888-srr B-carotene absorption and (ferret), 108:719 cholera toxin and (rat), 108:2-tmig, 108:34 colonic permeation of inulin and (rat), 108:12 cystic fibrosis transmernbrane conductance regulator and (rat, human), 108:1016 epithelial cell proliferation and (mouse), 108:1745 flow rate and, 108:983 lactulose/mannitoi permeability ratios and (cat, human, rodent), 108:687 mesalamine microgranule delivery in, 108:1338-tmig, 108:1427 myenteric denervation and (rat), 108:1629 pneumatosis cystoides intestinalis and, 108:1560-cr transforming growth factor c~ in, 108:571 srr transplantation, home parenteral nutrition and, 108:1005, 108:1302-e

Smoking gastric muscosa and, 108:1329-c inflammatory bowel disease and, 108:1616-tmig, 108:1683 intestinal permeability and, 108:1576-srr

Sigmoidoscopy

Smooth muscle

hereditary nonpolyposis colorectal cancer and, 108:1405 sulindac and, 108:1083 Signal t r a n s d u c t i o n , hepatocellular, nitric oxide and, 108:841

cecal, endothelin receptors on (guinea pig), 108:51 cytokines and (rat), 108:1720 ileal, platelet-activating factor receptors and (guinea pig), 108:1666 intestinal, galanin receptors on (dog, guinea pig), 108:3 jejunal, myenteric denervation and (rat), 108:1629 Snare cautery r e m o v a l , pyogenic granuloma in Barrett's esophagus and, 108:1894-cr Sodiunt acetate, dietary ammonium-induced hypergastrinemia and (rat), 108:l-tmig, 108:320 S o d i u m chloride, intestinal permeability and, 108:1569-srr S o d i u m d o d e c y l sylfate (SDS), mi~ crosomal autoantibodies in viral hepatitis and, 108:455 S o d i u m h a n d l i n g , in preascitic cirrhosis, 108:1820

Single paracellular p e r m e a t i o n m o d e l , intestinal permeability and, 108:1572-srr

Single-strand c o n f o r m a t i o n polym o e p h i s m (SSCP), hepatitis C virus and, 108:789

S k e l e t a l s y s t e m , Wilson's disease and, 108:885-cr S k i n , after photodynamic therapy for esophageal cancer, 108:337 S l a u g h t e r and p r o c e s s i n g , E. coli O157:H7 and, 108:1927-aga

Sleep neurobiology of, colonic motor patterns and, 108:1609-c periods, gastroesophageal reflux in ambulant subjects and, 108:83 S l o w - w a v e dysrhythtnias, gastric, hyperglycemia-evoked, 108:623-tmig, 108:727

Small h e p a t o c e l l u l a r carcinoma,

Sodium nitroprnsside colonic myoelectric complexes and (mouse), 108:1371 nitric oxide and (cat), 108:1215

S o d i u m sulfate, in fecal Na + and K + excretion, 108:752

Soft d r i n k s , heartburn and, 108:2-tmig, 108:125

Solvent drag, colonic permeation of inulin and (rat), 108:12

Somatic s t i m u l i gut distension and, 108:680 irritable bowel syndrome and, 108:636, 108:927-e

Somatic t r a n s c u t a n e o u s elecrical nerve s t i m u l a t i o n , irritable bowel syndrome and, 108:636, 108:927-e

Somatostatin cholangiocarcinoma and, 108:1908-rc GI tract endocrine ceils and (db/db mice), 108:967 N%methyl histamine in Helicobacter pylori infection and, 108:958-tmig, 108:959 Sorbitol, in fecal Na + and K + excretion, 108:752 S o u t h e r n b l o t analysis, hepatitis B virus and, 108:1810

S p a t i o t e m p o r a l reflux characteristics, gastroesophageal reflux disease and, 108:1739

Special diet p r o d u c t s , role of, 108:1294-aga

Special R e p o r t s a n d R e v i e w s Amino acid transport by small intestinal, hepatic, and pancreatic epithelia, 108:888 Conceptual advances in the pathogenesis and treatment of childhood metabolic liver disease, 108:1263 Crohn's disease: pathogenesis and persistent measles virus infection, 108:911 Epidermal growth factor-related peptides and their relevance to gastrointestinal pathophysiology, 108:564 Intestinal permeability: an overview, 108:1566 Liver cell necrosis: cellular mechanisms and clinical implications, 108:252 Plurichemical transmission and chemical coding of neurons in the digestive tract, 108:554 Role of acid and duodenogastric reflux in esophageal mucosal injury: a review of animal and human studies, 108:1897 S p e c t r o p h o t o m e t r y , NO synthase in portal hypertension and (rat), 108:1487 S p h i n c t e r o f Oddi, dysfunction caused by ampullary neoplasm, 108:242-cr S p i n a l reflex control, of anorectal function, 108:990

Spindle cells

June 1995

antral vascular ectasia and, 108:138 monocyte-chemoattractant protein 1 and, 108:40 Splenectomy, liver transplantation for chronic hepatitis with common variable immunodeficiency and, 108:879-cr Splenic flexure, colonic sarcoidosis and, 108:1556-cr Spores, microsporidial, HIV-associated necrotizing cholangitis caused by Septara intestinalis and, 108:247-cr Squamous cell carcinoma, esophageal, 108:310-tmig, 108:337, 108:545-cr, 108:1605-c Squeeze pressure, anal sphincter, rectoanal inhibitory reflex and, 108:1700 Src kinase, premalignant colon lesions and, 108:117, 108:291-e S S T R 2 , cholangiocarcinoma and, 108:1908-rc Stachyose, intestinal permeability and, 108:1569-srr Starvation, amino acid transport and, 108:902-srr Staurosporin, IL-8 in HT-29 cells and, 108:653 Steatobepatitis, nonalcoholic, prognosis in, 108:1607-c Steatovrhea stools, fecal consistency in diarrhea and, 108:1729

Stenosis esophageal, after photodynamic therapy for esophageal cancer, 108:337 shunt, TIPS and, 108:1143

SUBJECT INDEX

hyperglycemia-evoked slow-wave dysrhythmias and, 108:623-tmig, 108:727 lumen, Helicobacter pylori and (rat), 108:320 N%methyl histamine in Helicobacter py/ori infection and, 108:958-tmig, 108:959 mucosa lipase and, 108:1650 pepsin and, 108:1650 phospholipids and, 108:304-c secondary biliary cirrhosis and (rat), 108:1183 sensitivty to distension and, 108:330 sympathetic nervous system and, 108:680 transforming growth factor o~in, 108:570srr zymogenic cell differentiation and (transgenic mice), 108:447 Stool composition, dietary stimulation of bifodobacteria and, 108:975 Strain-gauge manometry, tongue force modulation and, 108:1418 S t r a i n i n g , gastroesophageal reflux in ambulant subjects and, 108:83 Streptococcus pyogenes, colonization of cholesterol gallstones and, 108:861 Streptococcus spp., Crohn's disease and, 108:I338-tmig, 108:1396

Stress brain and gut connection in, 108:618-c hyperosmolar, intestinal permeability and, 108:1569-srr myenteric denervation of jejunum and (rat), 108:1629

Steroids

Stretch

colonic sarcoidosis and, 108:1556-cr Crohn's disease and, 108:1935-e interleukin 10 in IBD and, 108:1434 osteopenia and, 108:417 Sterols, liver disease and, 108:1337-tmig, 108:1534

atrial natriuretic peptide in cirrhosis and (rat), 108:1496 esophageal sensitization in noncardiac pain and, 108:311 S t r i c t u r e s , pyogenic granuloma in Barrett's esophagus and, 108:1894-cr

Stomach

Submental electromyography

antrum, dietary ammonium-induced hypergastrinemia and (rat), 108:309tmig, 108:320 cancer, gastric dysplasia and, 108:1955-c chief cells, pepsinogen secretion and (guinea pig), 108:1709 Crohn's disease and, 108:1246-cr distension, glucose effects on colon motility and, 108:309-tmig, 108:350 ECL cells, circulating pancreastatin and (rat), 108:1445 epidermal growth factor stability in gastric juice and, 108:92 gastroesophageal reflux in ambulant subjects and, 108:83 ghosts in, 108:304-c Helicobacter fells and (mouse), 108:i386

deglutitive vocal cord closure and, 108:1337 lower esophageal sphincter tone and, 108:441 Substance P antagonist, neurogenic inflammation in intestine and (rat), 108:295-ss Sucrase, cystic fibrosis transmembrane conductance regulator and (rat, human), 108:1016

Sucrose behavior and cognitive performance affected by, 108:299-ss dietary stimulation of bifodobacteria and, 108:975 Sucrose gradient, discontinuous, buryrate uptake and (rat), 108:673

2011

S u l f a s a l a z i n e , Crohn's disease and, 108:1935-e S u l i n d a c , sporadic colonic polyps and, 108:1083, 108:1311-e Superfuslon assay, bile canalicular contraction and, 108:841 S u p e r i n f e c t i o n , hepatitis delta virus and, 108:796 Superoxlde, hepatic reperfusion injury and (rat), 108:463, 108:603-e Superoxide anion release, inflammatory bowel disease and, 108:21 Supplements, n u t r i t i o n a l , role of, 108:1296-aga

Supraconal spinal cord transection, anorectal function and, 108:990

Supranuclear/granular staining, genetic hemochromatosis and, 108:208

Surveillance programs colitis-associated neoplasias and, 108:383 hereditary nonpolyposis colorectal cancer and, 108:1590-e ulcerative colitis and, 108:1361

Survival rates home parenteral nutrition and, 108: 1302-e nonmalignant chronic intestinal failure and, 108:1005, 108:1302-e photodynamic therapy for esophageal cancer and, 108:310-tmig, 108:337, 108:593-e polycystic liver disease and, 108:487 TIPS and, 108:957-tmig, 108:1143 Zollinger-Ellison syndrome and, 108:1637 SW480 c e l l s , human spasmolytic polypeptide and, 108:108

Swallow deglutitive vocal cord closure and, 108:1357 gastroesophageal reflux in ambulant subjects and, 108:83 lower esophageal sphincter tone and, 108:441 Sweden, primary sclerosing cholangitis and, 108:870, 108:937-e

Swimming-associated outbreak, hemorrhagic colitis and, 108:1597-ss

Sympathetic nervous system gut distension and, 108:680 histamine ileal vasodilatory mechanisms and (guinea pig), 108:712

Symptom associations gastroesophageal reflux disease and, 108:1739 gold standard for assessing, 108:1959-c Synthesized protein assay, of APC mutations, 108:383

2012

SUBJECT INDEX

T 8 4 c e l l m o n o l a y e r s , eosinophil migration across, 108:409 Tachygastric a c t i v i t y , hyperglycemiaevoked gastric slow-wave dysrhythmias and, 108:623-tmig, 108:727 T a i w a n , hepatitis delta virus and, 108:623tmig, 108:796 T a u r i n e , 6-fluoro-ursodeoxycholic acid analogue and, 108:1204 Taurochenodeoxycholate, kinesin inhibition by (rat), 108:824

TaurochenodeoxychoHc acid, 6fluoro-ursodeoxycholicacid analogue and, 108:1204

Taurocholate cholesterol 7c¢-hydroxylase and (rat), 108:533 leukotriene C4 synthesis and (rat), 108:1793 Taurocholic acid, colonic permeation of inulin and (rat), 108:12 Tauroursodeoxycholate, kinesin inhibition by (rat), 108:824 99mTc-atbulnin colloid, 45 MBq, [13]acetate breath test for gastric emptying and, 108:1048 99mTc-DTPA, intestinal permeability and, 108:1569-srr

T-cells genomic variations in precore/core gene of hepatitis B virus and, 108:310-tmig, 108:505 VCAM-1 in chronic viral hepatitis and, 108:231 T e a , heartburn and, 108:125 T e r m i n a l differentiation, of zymogenic ceils (transgenic mice), 108:447 Testiculag cancer, pyogenic granuloma in Barrett's esophagus and, 108:1894-cr

Tetrodotoxin colonic myoelectric complexes and (mouse), 108:1371 histamine ileal vasodilatory mechanisms and (guinea pig), 108:712 histamine in duodenal bicarbonate secretion and (rabbit), 108:1676 Thapsigargin, ileal crypts and (mouse), 108:1345

Theophylline cirrhosis and (rat), 108:1504 cryptosporidiosis and (piglet), 108:1030 Thin-layer chromatography, intestinal permeability and, 108:1569-srr Thiopegamide, histamine ileal vasodilatory mechanisms and (guinea pig), i08:712

This Month in GASTROENTEROLOGY AIDS enteric infection: what is the problem?, 108:624

GASTROENTEROLOGY Vol. 108, No. 6

Another piece of the H. pylori puzzle, 108:958 Anti-inflammatory food, 108:957 Autoantibodies in colitis and cholangitis, 108:1615 Bacteria and cirrhosis: a bad combination, 108:1616 Big MAC, 108:309 Cholera toxin: the big picture, 108:2 Closing in on hemochromatosis, 108:1 Crohn's disease prophylaxis, 108:1615 Crypto counts, 108:957 Cyst fenestration, 108:309 Delta viremia, 108:623 Ethanol's one-two punch, 108:1 Feeding the microflora, 108:958 Gallbladder contraction: the strong and the weak, 108:1615 Gallstone geology, 108:624 Are gallstones a form of liver disease?, 108:1337 Glucose is an intestinal brake, 108:1616 Glucose regulates colonic motility, 108:309 Heartburn by the can, 108:2 Hepatitis C genotyping predicts posttransplant recurrence, 108:958 Hepatitis E viremia, 108:1 Hepatoma surveillance, 108:624 Hyperglycemia slows the stomach, 108:623 Interferon failure, 108:1 Interleukin 10: new therapy for inflammatory bowel disease?, 108:1338 Limited role for octretide in AIDS-associate diarrhea, 108:1616 £isteria and Crohn's disease, 108:1337 Mercyism, 108:957 Mesalamine delivery, 108:1338 Mutant viruses are resistant to interferon, 108:310 A new breath test for gastric emptying, 108:957 New Crohn's clues, 108:2 New cyst twist, 108:958 A new hypothesis for Crohn's disease, 108:623 NH 3 gastropathy, 108:309 Novel therapy with dummy receptor, 108:1616 Photodynamic therapy for esophageal cancer, 108:310 Polyp occurrence and recurrence, 108:309 Preventing postoperative Crohn's recurrence, 108:310 Quasispecies of hepatitis C virus, 108:623 Refrigerated livers, 108:1337 Screening for genetic colon cancer, 108:1337 Simplifying Helicobacterpylori treatment, 108:1338

Smoking risk lower in Israel, 108:1616 TIPS at two, 108:957 Tumor necrosis factor and hepatitis, 108:1337 When is polypectomy enough?, 108:1615

Three permeation pathway hypothesis, intestinal permeability and, 108:1570-srr T h r e o n i n e , refrigerated donor livers and, 108:1510

Thrombosis antral vascular ectasia and, 108:138 inflammatory bowel disease and, 108:1011, 108:1305-e portal vein, hepatic arterial resistance and, 108:1152

Thrombotic mesenteric microvascular occlusion, inflammatory bowel disease and, 108:1011, 108:1305-e

[3H]Thymidine hepatocellular DNA synthesis and (rat), 108:477 HepG2 cells and, 108:515 human spasmolytic polypeptide and, 108:108 Tight junctions, pancreatitis and (rat), 108:1863 Tissue culture, gastric ethanol metabolism and (rat), 108:737 Tissue repair, IGF-1 binding sites in colitis and (rat), 108:644

T-lymphocytes apheresis, Crohn's disease and, 108:952< cytotoxic, TNF-a' in HBV and, 108:1337tmig, 108:1453 T N M s t a g i n g , simplified, for hepatocellular carcinoma, 108:617-c ¢x-Tocopherol, in [~-carotene absorption (ferret), 108:719 T o l u i d i n e b l u e s t a i n i n g , human spasmolytic polypeptide and, 108:108 Tomato j u i c e , heartburn and, 108:125 Tongue force modulation, deglutitire, 108:1418

Total parenteral nutrition (TPN), childhood chronic intestinal pseudoobstruction and, 108:1379 T o x i n s ~ cholera (rat), 108:2-tmig, 108:34, 108:287-e Tracheostomy, vocal cord closure and, 108:1357

Transaminases IFN-ex for HBV in HIV infection and, 108:l-tmig leakage of, refrigerated donor livers and, 108:1337-tmig, 108:1510 TNF-~ in HBV and, 108:1337-tmig, 108:1453

Transcutaneous electrical nerve

June 1995

SUBJECT INDEX

stimulation, gut distension and,

Trichinella spiralis, intestinal

108:680

smooth muscle and (rat), 108:1720 Triglycerides, HepG2 cells and, 108:515

Transepithelial short-circuit current, octreotide and (prairie dog), 108:1547

Transforming growth factor (x

(T6F-u) angiogenesis in pancreatic cancer and (Syrian hamster), 108:1526 gastrointestinal pathophysiology and, 108:568-srr zymogenic cell differentiation and (transgenic mice), 108:447

Transforming growth factor (TGF-~), administration systems for, 108:1963<

Transforming growth factor ~1 (TGF-~I) liver disease and, 108:145 pancreatitis and, 108:1873 Transfusion, infection in bleeding cirrhotic patients and, 108:1828 Transgenic m i c e , zymogenic cell differentiation in, 108:447

Transjuguiar intrahepatic portosystemic shunt (TIPS), for variceal bleeding, 108:954-c, 108:957tmig, 108:1143 Transjugular venography, TIPS and, 108:1143 Transmembrane potentials, HC1 and (rabbit), 108:662

Transmucosal electrical nerve s t i m u l a t i o n , irritable bowel syndrome and, 108:636, 108:927-e

Transmucosal electrical potential difference, duodenal HCO~- secretion and, 108:102

Transplantation kidney, changing prevalence of HCV genotypes and, 108:581-rc liver alcoholism and, 108:615-br cholangiocarcinoma in primary sclerosing cholangitis and, 108:865 for chronic hepatitis with common variable immunodeficiency, 108:879-cr HCV genotyping and, 108:958-tmig, 108:1088, 108:I314-e intestinal permeability and, 108:1576srr refrigerated donor livers and, 108:1337tmig, 108:1510 small bowel, home parenteral nutrition and, 108:1005, 108:1302-e

Transsynaptic retrograde tract tracing, of NO synthase in brainstem (rat), 108:367

Transversion mutations, K-ras-2 in colon cancer and, 108:1040

Trauma formulas, role of, 108:1296-aga

2,4, 6-Trinitrobenzenesulfonic acid colitis and (at), 108:644 platelet-activating factor receptors and (guinea pig), 108:1666 Triple therapy, for Helicobacterpylori, 108:1338-tmig, 108:1412 Tropical sprue, intestinal permeability and, 108:1575-srr T r y p s i n , duodenogastric reflux and, 108:1903-srr Trypsinogen, pancreatic, liver development and, 108:1236 Tryptophan, quinoliDic acid and, 108:818

Tube feeding guidelines for use of, 108:1280-aga technical review, 108:1282-aga Tumor invasion, oz6-integrin in pancreatic cancer and, 108:523 Tumor markers, serum, for cholangiocarcinoma in primary sclerosing cholangitis, 108:865

Tumor necrosis factor (TNF) Helicobacter pylori infection and, 108:65 IL-10 in pancreatitis and, 108:1917-rc NSAID gastropathy and (rat), i08:393

Tumor necrosis factor a (TNF-~) hepatitis B virus and, 108:1337-tmig, 108:1453 HT-29 cells and, 108:653 inflammatory bowel disease and, 108:21, I08:284-e interleukin 10 in IBD and, 108:1338tmig, 108:1434 portal hypertension and (rat), 108:761 soluble receptor, carbon tetrachloride liver injury and (rat), 108:1616-tmig, 108:1849

Tumor staging esophageal cancer and, 108:337 hepatocellular carcinoma and, 108:617-c hereditary nonpolyposis colorectal cancer and, 108:1405 hypergastrinemia in colon cancer and (rat), 108:1068 malignant colorectal polyps and, 108:1657 Tyrosine, GI tract endocrine cells and (db/ db mice), 108:967 Tyrosine kinases, premalignant colon lesions and, 108:117, 108:291-e Tyrosinemia, hereditary, in children, 108:1263-srr

Ulcerative colitis antineutrophil cytoplasmic antibodies and, 108:423, 108:597-e, 108:1159 colon cancer and, 108:1321-ss

2013

dexamethasone-fl-D-glucuronide and (rat), 108:1688 heterogeneity and, 108:597< HLA-DR2 and, 108:423, 108:597-e Hsp60 expression and, 108:75 interleukin 10 in IBD and, 108:1434 Listeria monocytogenes and, 108:1338-tmig, 108:1396 low-grade dysplasia and, 108:1610< mesalamine and, 108:1889-cr monocyte-chemoattractant protein 1 and, 108:40 osteopenia and, 108:417 smoking and, 108:1683

Ulcers colonic sarcoidosis and, 108:1556-cr Crohn's disease and, 108:1396 duodenal, Helicobacterpylori and, 108:1338-tmig, 108:1412 gastric, secondary biliary cirrhosis and (rat), 108:1183 human spasmolytic polypeptide and, 108:108 Lister/a monocytogenes and, 108:1338-tmig, 108:1396

Ultrasonography atrial nan'iuretic peptide in cirrhosis and (rat), I08:1496 cholangiocarcinoma in primary sclerosing cholangitis and, 108:865 gallbladder emptying and, 108:1882 hepatocellular carcinoma and, 108:624tmig, 108:812, 108:1778 HIV-associated necrotizing cholangitis and, 108:247-cr pyogenic granuloma in Barrett's esophagus and, 108:1894-cr United States~ digestive diseases in, 108:947-br

University of Wisconsin preservation f l u i d free radical production after cold storage and (rat), 108:1167 refrigerated donor livers and, 108:1337tmig, 108:1510 Up-regulation, of IGF-1 binding sites in colitis (rat), 108:644 Urea, intestinal permeability and, 108:983 Urease, Helicobacterpylori (rat), 108:309tmig, 108:320 Uremia, intestinal permeability and, 108:1576-srr Urethane, pancreatic polypeptide and (rat), 108:1517

Uridine diphosphate (UDP)-glucutonic acid, in liver microsomal vesicles (rat), 108:183

Uridine diphosphate-glucuronosyltransferase (UGT) liver injury and, 108:i464

2014

SUBJECT INDEX

microsomai autoantibodies in viral hepatitis and, 108:435 U r o s e p s i s , sulindac and, 108:1083 U r s o d e o x y c h o l a t e , kinesin inhibition by (rat), 108:824

U r s o d e o x y c h o l i c acid 6-fluoro analogue of (hamster, rat), 108:1204 intestinal permeability and, 108:1576-srr primary biliary cirrhosis and, 108:1470, 108:1592-e U s s i n g c h a m b e r t e c h n i q u e s , cryptosporidiosis and (piglet), 108:1030

GASTROENTEROLOGY Vol. 108, No. 6

Venular s t e n o s i s , liver transplantation for chronic hepatitis with common variable immunodeficiency and, 108:879-cr V e n o u s i n v a s i o n , malignant colorectal polyps and, 108:1657

Very late activation antigen) VLA4), eosinophil migration and, 108:409

Vesicular t r a n s p o r t , kinesin and (rat), 108:824

V i d e o e n d o s c o p y , deglutitive vocal cord closure and, 108:1357

V i d e o m i c r o s c o p y , histamine ileal vasoVacuolar-type H+-adenosine t r i p h o s p h a t a s e , pancreatic H+/ HCO 3- secretion and (pig), 108:850 V a g a l r e f l e x e s , gut distension and, 108:680 V a g a l t o n e , pancreatic polypeptide and (rat), 108:1517 V a g o t o m y , pancreatic polypeptide and (rat), 108:1517 V a r i c e a l b l e e d i n g , TIPS for, 108:954-c, 108:957-tmig, 108:1143

Vascular a d h e s i o n m o l e c u l e I ( V C A M - 1 ) , in chronic viral hepatitis, 108:231

Vascular e n d o t h e l i a l g r o w t h factor (VEGF), angiogenesis in pancreatic cancer and (Syrian hamster), 108:1526 Vascular e n d o t h e l i u m , Crohn's disease and, I08:911-srr V a s c u l a r i t y , angiogenesis in pancreatic cancer and (Syrian hamster), 108:1526 Vascular m a l f o r m a t i o n s , multiple focal nodular hyperplasia of liver and, 108:1256-cr Vascular o c c l u s i o n , inflammatory bowel disease and, 108:1011, 108:1305-e Vascular s u r g e r y , major, intestinal permeability and, 108:1576-srr Vascular t o n e , NO in ethanol-induced gastric mucosal injury and (rat), 108:58 Vasodilagation, TNF-c~ and (rat), 108:761

Vasodilation hepatic, atrial natriuretic peptide and (rat), 108:803 NO in ethanol-induced gastric mucosal injury and (rat), 108:58 secondary biliary cirrhosis and (rat), 108:1183 V a s o d i l a t o r m e c h a n i s m s , histamine, in ileum (guinea pig), 108:712 V e n t r i c l e s , atrial natriuretic peptide in cirrhosis and (rat), 108:1496

dilatory mechanisms and (guinea pig), I08:712

Viewpoints on Digestive Diseases Bone disease in cholestatic liver disease, 108:276 Gastroscopy is incomplete without biopsy: clinical relevance of distinguishing gastropathy from gastritis, 108:917 The pruritis or cholestasis: potential pathogenic and therapeutic implications of opioids, 108:1582 V i l l o u s a r c h i t e c t u r e , premalignant colon lesions and, 108:117 V i l l u s a t r o p h y , AIDS-related cryptosporidiosis and, 108:1075

Villus cells cryptosporidiosis and (piglet), 108:1030 cystic fibrosis transmembrane conductance regulator and (rat, human), 108:1016

Villus tips intestinal permeability and, 108:983 lactulose/mannitol permeability ratios and (cat, human, rodent), 108:687 Vinblastine, cytochrome P4502B traffic and (rat), 10811110 Viremia hepatitis B virus, 108:1810 hepatitis delta virus, 108:623-tmig, 108:796 hepatitis E virus, 108:l-tmig, 108:225 V i r u s s h e d d i n g , hepatitis E virus infection and, 1081225 Visceral afferents, rectoanai inhibitory reflex and, 108:1700 Visceral a n g i o g r a p h y , multiple focal nodular hyperplasia of liver and, 108:1256-cr V i s e e r o s o m a t i c referral, irritable bowel syndrome and, 108:636, 108:927-e Viscosity, tongue force modulation and, 108:1418 Vitamin A,/3-carotene conversion to (ferret), 108:719 V i t a m i n Bla a b s o r p t i o n , AIDS-related cryptosporidiosis and, 108:957-tmig, 108:1075

Vitamin D, osteopenia and, 108:417 Vitamin E [}-carotene absorption and (ferret), 108:719 fructose-l,6-biphosphate and (rat), 108:1785 Vm, HCI in esophageal ceils and (rabbit), 108:662 Vocal cord closure, deglutitive, 108:1357 Volitional control, tongue force modulation and, 108:1418 V o l u m e , tongue force modulation and, 108:1418 y o n Willebrand's d i s e a s e , inflammatory bowel disease and, 108:1011, 108:1305-e v - y e s o n c o g e n e , premalignant colon lesions and, 108:117

Wager brain, after hepatectomy rat), 108:1097 colonic transport of, cholera toxin and (rat), 108:2-tmig, 108:34 fecal consistency in diarrhea and, 108:1729 flux colonic permeation of inulin and (rat), 108:12 octreotide and (prairie dog), 108:1547 pharyngeal stimulation, lower esophageal sphincter tone and, 108:441 swallow, deglutitive vocal cord closure and, 108:1357 W E B - 2 0 8 6 , eosinophil migration and, 108:409 Weight g a i n , preascitic cirrhosis and, 108:1820

Weight l o s s amylase inhibition and (dog), 108:1221 colonic sarcoidosis and, 108:1556-cr rumination syndrome and, 108:1024

Western b l o t analysis carbonic anhydrase and, 108:1802 microsomal autoantibodies in viral hepatitis and, 108:455 Wheat a m y l a s e i n h E b i t o r , carbohydrate digestion and (dog), 108:1221 White b l o o d cells ( W B C s ) , peripheral, opioid binding in cholestasis and (rat), 108:1479

Wilson's d i s e a s e acute rhabdomyolisis in, 108:885-cr childhood, 108:1268-srr liver cell necrosis and, 108:264-srr Wines, heartburn and, 108:2-tmig, 108:125

Women intestinal permeability in, 108:1575-srr multiple focal nodular hyperplasia of liver in, 108:1256-cr rumination syndrome in, 108:1024

June 1995

sexual abuse of, 108:1945-ss

Wounded m o n o l a y e r assay, human spasmolytic polypeptide and, 108:108

Xenobiotics, hepatic glucuronidation and (rat), 108:183

X r e g i o n deletion mutants, hepatitis B virus and, 108:1810

SUBJECT INDEX

Xylose AIDS-related cryptosporidiosis and, 108:957-tmig, 108:1075 intestinal permeability and, 108:983, 108:1569-srr

Yamaguchi 7 3 v i r u s , premalignanr colon lesions and, 108:117

Yellow p h e n o l p h t h a l e i n , in fecal Na + and K + excretion, 108:752

2015

Yes k i n a s e a c t i v i t y , in colonic adenomas, 108:117, 108:291-e ZO-1 p r o t e i n , pancreatitis and (rat), 108:1863

ZoIlinger- Elision s y n d r o m e metastatic rate and survival in, 108: 1637 surgery and, 108:1600-ss Zy~ntogenic c e l l s , TGF-c~ in terminal differentiation of (transgenic mice), i08:447